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Abnormalities of cardiac rhythms are correlated with significant morbidity. For
example atrial fibrillation, affecting at least 2.3 million people in the United States,
is associated with an increased risk of both stroke and mortality; supra-ventricular
tachycardia, detected in approximately 90,000 cases annually in the United States,
results in hospitalization in about 25% of all emergency department visits for supra-
ventricular tachycardia; ventricular arrhythmias cause 75% to 80% of the cases of
sudden cardiac death; bradyarrhythmias and other forms of conduction disease may
cause syncope, fatigue from chronotropic incompetence, or sudden death from asystole
or ventricular tachycardia. Due to the time-sensitive nature of cardiac events, it is
of utmost importance to ensure that medical intervention is provided in a timely
manner, which could benefit greatly from a cardiac arrhythmia monitoring system
that can detect and preferably also predict the abnormal cardiac events.
In recent years, with the development of cardiac and other types of medical mon-
itoring devices, vast amounts of physiological signal data have been collected and
become available for analysis. Physiological signals such as electrocardiogram (ECG)
have many clinical applications in cardiac arrhythmia, including diagnosis confirma-
tion, drug effect monitoring and rate control. However, the extraction of the relevant
information from physiological signals—despite its great value—is hindered by the
complexity and variability within signal morphology, which leads to vague definitions
and ambiguous guidelines, causing difficulties even for a well-trained medical expert.
xv
Such variability-related issues are ubiquitous and manifested in different ways: via
the ECG signals themselves, the measurements derived from such signals, and the
diagnostic interpretations based on such measurements.
In order to address the variability-related issues, most traditional methods for
physiological signal analysis depend heavily on pre-processing to identify specific mor-
phology types (such as R peaks in ECG) and extract the related features. Despite
many successes, one of the drawbacks of these methods is that they often require signal
data of high quality and tend to be less effective in the presence of noise which could
significantly distort the signal morphology. Although not an issue in almost noise-
less situations such as bedside ECG monitoring, such pre-processing–based methods
have become insufficient with the advent of portable arrhythmia monitoring devices
in recent years capable of collecting physiological signals in real time, albeit with
more noise. Therefore, in order to enable automated clinical decision making using
such ECG sources, it is desirable to introduce new methods that require minimal
pre-processing prior to analysis and are robust to noise.
This thesis aims to develop a cardiac arrhythmia monitoring and prediction sys-
tem applicable to portable arrhythmia monitoring devices. The analysis is based
on a novel algorithm which does not rely on the detailed morphological information
contained within each heartbeat, thus minimizing the impact of noise. Instead, the
method works by analyzing the similarity and variability within strings of consecu-
tive heartbeats, relying only on the broad morphology type of each heartbeat and
utilizing the computer’s ability to store and process a large number of heartbeats be-
yond humanly possible. The novel algorithm is based on deterministic probabilistic
finite-state automata which have found great success in the field of natural language
processing by studying the relation among different words in a sentence rather than
the detailed structure of the individual words.
The proposed algorithm has been employed in experiments on both detection
xvi
and prediction of various cardiac arrhythmia types, and has achieved an Area un-
der the ROC Curve (AUC) in the range of 0.70 to 0.95 for detection and prediction
of different types of cardiac arrhythmias and cardiac events including atrial fibril-
lation, supraventricular tachycardia, ventricular arrhythmia, ventricular tachycardia,
bradycardia, and rapid ventricular rates with publicly available benchmark databases,
hospital bedside database and data collected from portable devices. Comparing with
other well-established methods, the proposed algorithm has achieved equal or better
classification results, even though in some cases the advantage might not be statis-
tically significant. In addition, the performance of the proposed algorithm is almost
identical with or without any pre-processing on the data.
The work in the thesis could be deployed as a cardiac arrhythmia monitoring
and severe event prediction system which could alert patients and clinicians of an




1.1 Motivation and Background
The long-term goal of this thesis is to develop a cardiac arrhythmia monitoring
system that not only detects but also predicts abnormal cardiac events.
Abnormalities of cardiac rhythms are correlated with significant morbidity. Atrial
fibrillation, supra-ventricular tachycardia, ventricular arrhythmia and bradycardia
are all common types of cardiac arrhythmia. Atrial fibrillation is the most common
sustained cardiac arrhythmia occurring in 1-2 % of the general population Camm
et al. (2010), the percentage will likely keep growing between 2012 and 2050, when
the United States will experience considerable growth in its elder population Jan-
uary et al. (2014); Ortman et al. (2014). Atrial fibrillation (AFib) affects at least
2.3 million people in United States and is associated with an increased risk of stroke
and mortality. Supraventricular tachycardia (SVT) is a general term describing a
subgroup of arrhythmias whose mechanism involves or originates above the atrioven-
tricular node. About 90,000 cases of SVT are detected annually in the United States
and about 25% of all emergency department visits for SVT result in hospitalization.
Ventricular arrhythmia (VA) encompasses a spectrum of abnormal heart rhythms
originating from the ventricles, the heart’s lower chambers. VA causes 75% to 80%
of cases of sudden cardiac death. Bradyarrhythmias and other forms of conduction
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disease may cause syncope, fatigue from chronotropic incompetence, or sudden death
from asystole or ventricular tachycardia. Therefore it is crucial to develop a cardiac
arrhythmia monitoring system that can not only detect the abnormal cardiac events
but also predict these events.
Physiological signals such as ECG have many clinical applications in cardiac ar-
rhythmia, including diagnosis confirmation, monitoring drug effects, and rate control
Lankveld et al. (2014). In recent years, with development of cardiac monitoring de-
vices, more physiological signals are obtained and digitalized and available for anal-
ysis. Despite its great value, it is often challenging to extract relevant information
from physiological signals, even for a well-trained medical expert, due to variability
in signal morphology. Such variability is ubiquitous and manifests itself in different
ways: via the ECG signals themselves, the measurements derived from such signals,
and the diagnostic interpretations based on such measurements Schijvenaars et al.
(2008).
1.2 Current Approaches and Challenges
Most traditional methods for physiological signal analysis depend heavily on pre-
processing to identify specific morphology (such as R peaks in ECG). As a result, these
methods tend to be less effective on noisy data. In recent years, with the advent of
portable arrhythmia monitoring devices, it has become possible to collect ECG data
in real time, albeit with more noise. Therefore, in order to enable automated clinical
decision making using such ECG sources, it is desirable to introduce new methods
that require minimal pre-processing prior to analysis.
In this thesis, we aim to develop a cardiac arrhythmia monitoring and prediction
system with a novel deterministic probabilistic finite-state automata (DPFA) based
approach. The method transforms physiological signals into probabilistic strings over
an alphabet which contains a list of symbols. Each symbol of the alphabet corre-
2
sponds to a broad morphology type which is present in the physiological signal in
question. Using these probabilistic strings obtained from the physiological signals via
symbolization, the algorithm seeks to extract the information related to the patterns
and sequences of the symbols contained in the probabilistic string. This is achieved
by constructing a DPFA from the probabilistic string, after which the DPFA serves
as the primary means of classification. This approach frees the resultant classification
algorithm from relying on the identification of specific morphological information such
as the location of R peaks in ECG. The proposed approach does not rely on extensive
clinical knowledge regarding the specific morphology of the signals, and is robust to
noise in the signals.
1.3 Outline of Thesis Study
This thesis aims to develop a cardiac arrhythmia monitoring and prediction sys-
tem. The central component is a novel DPFA-based algorithm which is developed
and tested on different types of data. The rest of this thesis is organized as follows.
Chapter II provides an extensive literature review of the background and current
development and applications of arrhythmia classification and prediction algorithms,
together with various types of arrhythmia that are considered in our detection and
prediction experiments, using physiological signals such as ECG and accelerometer
data.
Chapter III contains the detailed information on the various algorithms used in
this thesis. These include the automated annotation algorithms for different types of
arrhythmia and cardiac events, which are used in experiments where there is no an-
notations done by clinicians, the pre-processing, noise detection and event extraction
algorithms involved in various auxiliary steps of the experiments, and most impor-
tantly the DPFA algorithm.
Chapter IV describes data sources that have been used for this thesis. There is
3
a total of six databases, each has been experimented on for different purposes of the
study. Database 1 (DB1) is used in the earlier stages of the thesis for algorithm
development and events detection. Database 2 (DB2) is collected in-hospital from
bed-sides devices and used for arrhythmia prediction. Database 3 (DB3) has not
been collected as planned and eventually combined with Database 4 (DB4). DB4
and Database 5 (DB5) are prospective databases with portable devices for hospi-
tal discharged patients and healthy controls. These two databases have been used
for arrhythmia predictions. Database 6 (DB6) is a database with signals collected
from portable devices on AFib patients. This dataset is also used for cardiac event
prediction.
Chapter V presents the results of all the experiments conducted during the thesis
study. These include detection and prediction of AFib, SVT, VA, bradycardia and
rapid ventricular rates (RVR) with low activities. Discussions and limitations for the
monitoring and prediction events are also presented in this chapter.
1.4 Conclusion
This thesis presents a new method for classifying and predicting cardiac arrhyth-
mia events based on a novel DPFA algorithm. The proposed method takes a proba-
bilistic string extracted from physiological signals as input, and constructs the under-
lying state space and transition probabilities of the DPFA model, directly from the
input data via frequency analysis. Experiments have been performed on physiologi-
cal signals collected from different sources such as public databases, hospital bed-side
devices and portable devices to detect and predict different types of cardiac arrhyth-
mia events. The proposed algorithm requires minimal pre-processing and is robust to
noise. The work in the thesis could be deployed as a cardiac event prediction system






This chapter contains a background literature review conducted in three aspects.
Firstly, a review in different types of arrhythmia, including atrial fibrillation, supraven-
tricular tachycardia, ventricular arrhythmia and bradycardia. Secondly, a review in
physiological signals and ECG in particular as ECG data is the main data used in
the study for experiments. Finally a review in arrhythmia classification algorithms.
2.2 Types of Arrhythmia
One of the project objectives is to construct a reliable prediction system for car-
diac arrhythmia, specifically AFib, SVT, VA and bradycardia as they are the most
prevalent types of arrhythmia. In the sections below we will introduce different types
of arrhythmias and their significance.
2.2.1 Atrial Fibrillation
AFib is the most common sustained cardiac arrhythmia occurring in 1-2 % of
the general population Camm et al. (2010), the percentage will likely keep growing
between 2012 and 2050, when the United States will experience considerable growth
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in its elder population January et al. (2014); Ortman et al. (2014). AFib is the most
common sustained cardiac arrhythmia. As of 2014, between 2.7 million and 6.1 million
American adults were affected by AFib January et al. (2014). AFib is a major cause of
many life-threatening diseases and adversely impacts quality of life. It is associated
with a 5-fold increased risk of stroke Wolf et al. (1991), a 3-fold increased risk of
heart failure, and a 2-fold increased risk of both dementia and mortality January
et al. (2014); Wang et al. (2003); Kannel et al. (1998); Camm et al. (2010).
2.2.2 Supraventricular Tachycardia
SVT is a general term describing a subgroup of arrhythmias whose mechanism
involves or originates above the atrioventricular node. The incidence of SVT is ap-
proximately 35 cases per 100,000 patients with a prevalence of 2.25 cases per 1,000
in the general population Sohinki and Obel (2014). SVT has different arrhythmia re-
lated symptoms ranging from nonexistent to severe. Symptoms include palpitation,
fatigue, light-headedness, chest discomfort and dyspnea, while on the other extreme
certain paroxysmal SVT could also be asymptomatic.
2.2.3 Ventricular Arrhythmia
VA encompasses a spectrum of abnormal heart rhythms originating from the ven-
tricles, the heart’s lower chambers. These types of arrhythmia have rates of over 100
beats per minute Al-Khatib et al. (2018). Types of VA include ventricular tachy-
cardia (VT), ventricular flutter (VFlutter), and ventricular fibrillation (VF). Serious
ventricular arrhythmia is associated with ischemic heart disease and can contribute to
sudden cardiac death (SCD) events. These events constitute approximately 230,000
to 350,000 deaths annually in the United States and 50% of all cardiovascular deaths
Myerburg (2001); Myerburg and Junttila (2012). Approximately half of SCD events
can be attributed to VT or VF John et al. (2012). Therefore, monitoring and detect-
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ing VT and VF is critical for the prevention of SCD events.
2.2.4 Bradycardia
Among various types of arrhythmia, tachycardia refers to a fast heart beat gen-
erally with a resting heart rate greater than 100 beats-per-minute (BPM), whereas
bradycardia, on the other hand, refers to a slow heart beat commonly defined as
having a heart rate of less than 60 BPM Kusumoto et al. (2019). Despite the general
definition, a slow heart rate does not always indicate an underlying disease, since
there is considerable variation in the resting heart rate among the healthy, asymp-
tomatic population Mangrum and DiMarco (2000) such as the example of people
with a family history of slow heart beats, or athletes and physically active individ-
uals. However, bradycardia can cause inadequate blood flow to tissues and organs
leading to symptoms such as fatigue, dizziness or heart failure Mangrum and DiMarco
(2000).
2.3 Physiological Signals
Physiological signals reflect the functionality of various physiological systems. A
trained medical expert can retrieve valuable information about the structure of the
organ by examining the physiological signals generated by its electrical conduction
system. This knowledge has far reaching impact in decision making in diagnosis,
treatment monitoring, drug efficacy tests and quality of life Faust et al. (2018).
The ECG is a type of physiological signal with many clinical applications in car-
diac arrhythmia, including diagnosis confirmation, monitoring drug effects, and rate
control Lankveld et al. (2014). Despite its great value, it is often challenging to ex-
tract relevant information from ECG signals, even for a well-trained medical expert,
due to variability in signal morphology. Such variability is ubiquitous and manifests
itself in different ways: via the ECG signals themselves, the measurements derived
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from the signals, and the diagnostic interpretations based on such measurements.
2.4 Arrhythmia Classification Algorithms
Arrhythmia classification using ECG signals typically involves three major tasks:
signal pre-processing in order to remove noise and baseline wandering, feature extrac-
tion in time and/or frequency domains, and classification of the signals into different
arrhythmia types according to the features extracted, often through the training of
classifiers via machine learning algorithms.
In the literature, numerous feature extraction techniques have been proposed to
analyze and classify ECG signals. These techniques include: heart rate variabil-
ity (HRV) Asl et al. (2008); Mei et al. (2018), independent component analysis (ICA)
Yu and Chou (2009); Jiang et al. (2006); Naseri et al. (2019), principal component
analysis (PCA) Ceylan and Özbay (2007); Martis et al. (2012), wavelet transform
Mahmoodabadi et al. (2005); Zhao and Zhang (2005); Ashtiyani et al. (2018), con-
volutional neural network (CNN) Acharya et al. (2017a); Kiranyaz et al. (2016).
These feature extraction techniques are used together with learning algorithms for
arrhythmia detection and classification. Each feature extraction technique focuses
on different aspects of the signal, e.g., HRV features put emphasis on the features of
heart beats, while ICA, PCA, and wavelet transform focus on the morphology of the
signal. All of these methods have their unique strengths and drawbacks.
The machine learning algorithms used for arrhythmia classification include: sup-
port vector machine (SVM) Ye et al. (2010); Nasiri et al. (2009); Song et al. (2005);
Ozcan and Gurgen (2010); Bazi et al. (2013), auto-regressive modeling Ge et al.
(2002), hidden Markov model (HMM) Coast et al. (1990); Andreao et al. (2006);
Gomes et al. (2010), a set of rules as determined by cardiologists Tsipouras et al.
(2002); Exarchos et al. (2005), optimal path forest Luz et al. (2013), and artificial
neural networks Ceylan and Özbay (2007); Jadhav et al. (2011); Özbay et al. (2006);
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Elhaj et al. (2016). In the past two years, many studies have adopted recurrent neu-
ral network (RNN) or long short-term memory (LSTM) as the learning algorithms
of choice Oh et al. (2018); Chauhan and Vig (2015); Yildirim (2018); Zhang et al.
(2017); Warrick and Homsi (2017). A number of studies have also applied deep learn-
ing methods for the classification of ECG signals Acharya et al. (2017a); Rajpurkar
et al. (2017); Acharya et al. (2017b). In general these algorithms do not require
specific signal pre-processing, QRS detection, or feature extraction steps. However,
this advantage comes with the cost of requiring larger training datasets. This can be
challenging as arrhythmia cases are relatively rare in comparison to healthy control
cases.
Contrary to the above, to the best of our knowledge few studies have applied
DPFA-based methods in the analysis of physiological signals, and especially not in
arrhythmia detection and prediction using ECG signals. DPFA are finite-state au-
tomata in which every state is assigned a probability to each distinct letter in a
fixed finite alphabet, which then determines a unique new state. More generally, in
probabilistic finite-state automata (PFA), given a letter and current state, multiple
transitions are allowed to other states with potentially different probabilities Vidal
et al. (2005). PFA have the same expressive power as HMM Vidal et al. (2005), de-
spite the fact that only the latter has found wide application in ECG signal analysis.
Due to its deterministic assignment of transitions to the alphabet for a given
state, DPFA have less expressive power than PFA. On the other hand, it is much
easier to estimate the parameter values of DPFA than PFA Vidal et al. (2005). As
a result, DPFA will likely perform better when running the algorithm in real-time.
Some well-developed special cases of DPFA include: n-grams with smoothing Ney
et al. (1997), Markov chains built by aggregating or mixing n-grams Saul and Pereira
(1997), and probabilistic suffix trees (PST) Esposito et al. (2002). These algorithms
have found applications in natural language processing Brown et al. (1992); Hakki-
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nen and Tian (2001) as well as in biomedical research such as protein structural
analysis and sequence analysis Dorohonceanu and Nevill-Manning (2000); Oğul and
Mumcuoğlu (2006).
2.4.1 Arrhythmia Prediction
As detailed above, many algorithms and methods exist for the detection or classi-
fication of cardiac arrhythmias. A more challenging application of machine learning
in this context is the prediction of cardiac events or arrhythmias before they occur.
A reliable cardiac event prediction system could alert patients and clinicians alike
of an impending event, thereby enabling timely intervention. However, prediction of






This chapter contains a detailed description of the methodologies. There are
four major sections in this chapter. In the first section, the DPFA algorithm is
explained in detail including training method, symbolization, DPFA generation and
classification method. In the second section, the annotation algorithms for different
types of arrhythmia and cardiac events are described. In the third section, the pre-
processing steps and prediction event extractions steps are illustrated. In the last
section, several existing methods are listed and explained for comparison.
3.2 Deterministic Probabilistic Finite-State Automata
3.2.1 Training Method
A schematic diagram of the proposed method is illustrated in Figure 3.1. The
training dataset consists of annotated ECG signals. From these the algorithm extracts
windows that are indicative of future arrhythmia events and others that are not. The
positive ECG signals (i.e., pre-arrhythmia) are symbolized into probabilistic strings,
which are then fed into the DPFA Generation module that constructs the positive
DPFA M+. The same is done for the negative ECG windows (i.e., regions that are
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Figure 3.1: DPFA training, A schematic diagram depicting the training and testing
steps for the proposed method.
neither arrhythmia nor pre-arrhythmia), producing the negative DPFA M−. The
Symbolization module is detailed in Section 3.2.2 and the DPFA Generation module
is described in Section 3.2.3.
3.2.2 Symbolization
In this study, ECG signals are symbolized into strings of ternary words, but the
method can be extended to larger alphabets. Let g(t) be the input ECG signal, where
t is time in seconds, 0 ≤ t ≤ L, and L is the length of the ECG recording. g(t) can
be thought of as a continuous signal, but in implementation it is generally discrete
with a high frequency (typically ≥ 200 Hz) depending on the ECG source. The
symbolization process for a sample of ECG signal with normal rhythm is illustrated
in Figure 3.2 and a sample of ECG signal with VA is illustrated in Figure 3.3.
A brief description of the main steps of the symbolization process is below, with
pseudocode provided in Algorithm 1:
(a) The first step is to capture morphological features of width less than the dura-
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Figure 3.2: DPFA symbolization, an example of ECG signal symbolization into a
ternary alphabet: {p1,p2,q}.
Figure 3.3: DPFA symbolization, an example of VA ECG signal symbolization into
a ternary alphabet: {p1,p2,q}.




t−h0 g(r)dr over intervals of width 2h0. The signal is then smoothed
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by convolving with the triangle function Λh0(t) = max{h0 − |t|, 0} and normal-








over intervals of width 2h1.
The parameter h0 controls the window size for baseline removal, while h1 con-
trols the length of the filter whose purpose is to capture the variability of mag-
nitudes among adjacent heartbeats, while ensuring comparable average magni-
tudes over longer intervals. Therefore h0 should be approximately the duration
of a heart beat. Since a normal heart rate is around 60-100 beats per minute,
so h0 was chosen to be 2 seconds. h1 needs to be longer than the duration
of two or three heartbeats, but not too large as to reduce the local nature of
normalization, so h1 was chosen to be 5 seconds. Both parameters can also
be tuned during the training steps for the purpose of facilitating the capture
of local information for use by the DPFA algorithm. For different applications
these parameters may need to be modified.
Finally a piecewise linear filter is applied by forming the convolution
g ∗ φ(t) = g(−2) ∗ φ(2)(t),
where g(−2) denotes the second antiderivative of the signal g(t) and φ(2)(t) de-
notes the second derivative of the piecewise linear function φ(t). The expression
on the right hand side has the advantage that φ(2) is a sum of delta functions,
which is better behaved when working with discrete signals.
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∣∣∣ (i− 1)w ≤ t ≤ iw},
where w is the downsampling window size tuned during the training step and
n = bL/wc.
(c) The next step is to locally normalize the discrete signal by dividing xi by the
local maximum max{xi−bh2/wc, . . . , xi+bh2/wc} over intervals of width 2h2, where
h2 = 1 second. h2 was chosen to be long enough to cover several QRS complexes.
(d) In the final step, the probabilities pi1, pi2 and qi are obtained from the normal-







qi = 1− pi1 − pi2,
where the soft-thresholding functions are chosen to be piecewise linear functions
ψ1, ψ2 : [0, 1]→ [0, 1] of the form
ψj(x) =

1 if x > bj
x−aj
bj−aj if aj ≤ x ≤ bj
0 if x < aj
The parameters a1, b1, a2, b2 are all different and tuned within the training step
for different studies. A grid search was performed for a1 and b1 with a1 < b1 from
0.1 through 0.9 with 0.1 increment. A grid search for a2 and b2 was performed
in a similar manner. The parameter values used in this study were selected
tuned with training and validation data.
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In summary, pi1, pi2, and qi represent the probability of dominant patterns and local
shapes depending on values of a1, b1, a2, and b2.
Algorithm 1 ECG Symbolization
Require: g(t), 0 ≤ t ≤ L . ECG
h0, h1, h2 > 0 . time parameters
φ(t), supported locally near t = 0 . piecewise linear filter
w > 0 . downsampling window size
ψ1, ψ2 : [0, 1]→ [0, 1] . soft-thresholding functions





 · · ·
pn1pn2
qn
 . probabilistic string




t−h0 g(r)dr . subtract moving average






2 g(t) . normalization
g(t)← g(−2) ∗ φ(2)(t) . piecewise linear filter
end for
n← bL/wc . length of P
for i← 1, n do
xi ← max{g(t) | (i− 1)w ≤ t ≤ iw} . downsampling
end for
for i← 1, n do
x̃i ← xi/max{xj | i− bh2/wc ≤ j ≤ i+ bh2/wc} ∈ [0, 1]
. local normalization
pi1 ← ψ1(x̃i)
pi2 ← (1− ψ1(x̃i))ψ2(x̃i)
qi ← 1− pi1 − pi2 . soft-thresholding
end for
3.2.3 DPFA Generation
The output of the symbolization module is a probabilistic string over the alpha-
bet Σ. Such a probabilistic string defines a word distribution, for which the DPFA
generation module produces a DPFA that best approximates this distribution. The
DPFA is constructed in two steps: first by building a frequency prefix tree (FPT)
and then performing state merging within the FPT.
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3.2.3.1 The Word Distribution Defined by a Probabilistic String
Given the alphabet Σ = {a1, . . . , ad} consisting of d symbols, let Σ∗ denote the
set of all words aj1aj2 . . . ajm of finite length, with ε representing the empty word. A
word distribution is defined to be a function f : Σ∗ → R such that




for all w ∈ Σ∗.











where pij denotes the probability that the ith letter of the probabilistic string is equal
to aj ∈ Σ. Then the probabilistic string defines a word distribution fP by






for all non-empty aj1aj2 . . . ajm ∈ Σ∗ and fP(ε) = n (see Algorithm 2).
3.2.3.2 Constructing the FPT
A frequency prefix tree (FPT) is a tree-like automaton T = 〈Q0,Σ, ε,Freq〉 with
alphabet Σ, state space Q0 ⊂ Σ∗, and initial state ε ∈ Q0, which is also equipped
with a frequency function Freq : Q0 → R. Here the transition function is given by
concatenation of words, which assigns qaj ∈ Σ∗ to (q, aj) ∈ Q0×Σ whenever qaj ∈ Q0.
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Algorithm 2 Word Distribution of a Probabilistic String
Require: P = p1p2 . . .pn . probabilistic string
Ensure: fP(w) ∈ R . w = aj1aj2 . . . ajm ∈ Σ∗
w ← ε
pn+1(w)← 0
for i← 1 to n do
pi(w)← 1
end for
for k ← 0 to m− 1 do
w ← ajm−kw
pi(w)← pijm−kpi+1(w)




In particular, a word distribution f : Σ∗ → R on the alphabet Σ defines an FPT
with full state space Q0 = Σ
∗ and frequency function Freq = f . In general, such
FPTs have infinite state spaces. However, in the special case when Freq(w) = 0 for
all but finitely many w ∈ Σ∗, the FPT can be restricted to the finite state space
Q0 = {w ∈ Σ∗ | Freq(w) 6= 0}
without losing any information.
One such special case is when the word distribution f arises from a probabilistic
string P over the alphabet Σ with finite length. This is because fP(w) = 0 for all
words w ∈ Σ∗ whose length exceeds the length of P.
3.2.3.3 Cutoff and State Merging
A deterministic probabilistic finite-state automaton (DPFA) is an automaton M =
〈Q,Σ, ε, P, T 〉 with state space Q, alphabet Σ, initial state ε ∈ Q and transition
function T : Q × Σ → Q, which is also equipped with a probability function P :
Q× Σ→ R such that




j=1 P (q, aj) = 1
for all q ∈ Q.
Given an FPT T = 〈Q0,Σ, ε,Freq〉, one can construct a DPFA M = 〈Q,Σ, ε, P, T 〉
by the largest suffix merging (LSM) algorithm (Algorithm 3); a brief description of
which is provided below:
(a) the algorithm requires a cutoff parameter C such that 0 < C < Freq(ε);
(b) the state space Q of the DPFA consists of all q ∈ Q0 which have frequency
Freq(q) > C;
(c) the alphabet Σ and initial state ε ∈ Q are the same as the FPT;
(d) the probability function is defined to be
P (q, aj) =
Freq(qaj)
Freq(q)
for all q ∈ Q, which is well-defined since Freq(q) > C > 0;
(e) if Freq(qaj) > C, then the transition function is defined to be T (q, aj) = qaj ∈
Q;
(f) otherwise T (q, aj) = s ∈ Q is defined to be the largest suffix s of qaj with
Freq(s) > C.
In summary, the LSM algorithm selects those states q ∈ Q0 of T with sufficiently high
frequency to be in the state space M , and then defines the transition state T (q, aj)
to be the largest suffix of qaj that is itself contained in the state space of M .
Figure 3.4 provides an example of an FPT, while Figure 3.5 depicts the DPFA
constructed by the LSM algorithm. For example, in Figure 3.5 the transition state
T (a, aba) is the largest suffix of abaa contained in the state space. Since abaa and
aba are not in the state space, T (a, aba) = aa.
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The mechanism for state merging in the LSM algorithm reflects the time-dependent
nature of the underlying data (i.e., ECG signals). In particular, the transition state
T (q, aj) is found by repeatedly deleting the left-most letter from the string qaj, which
represents the process of forgetting information from the most distant past, in order
to update the system to the current state.
Algorithm 3 Largest Suffix Merging
Require: T = 〈Q0,Σ, ε,Freq〉 . FPT
0 < C < Freq(ε) . cutoff parameter
Ensure: M = 〈Q,Σ, ε, P, T 〉 . DPFA
Q← {ε} . initial state
for all q ∈ Q0 do
while Freq(q) > C do











T (q, aj)← largest suffix of T (q, aj)
end while . transition function





When training the DPFA MP from the input probabilistic string P, there is no
need to construct the states of the FPT TP with frequency less than C, and the
LSM algorithm is executed to merge the states of TP immediately after they are
constructed.
The combined algorithm has computational complexity O(dns) and needs total
memory O(nl), where d is the size of the alphabet Σ, n is the length of the probabilistic
string P, s is the size of the state space Q, and l is the length of the longest word in
the state space Q. Both s and l depend on the cutoff parameter C.
20
Figure 3.4: DPFA generation, an example of FPT
FPT - The DPFA generation module searches through the tree. The yellow words have frequency
at least C, while the red words have frequency less than C. This example will generate a DPFA
with 8 states.
Figure 3.5: DPFA generation, an example of transition states
The DPFA generated from the previous figure. The transition state T (a, aba) is the largest suffix of
abaa contained in the state space. Since abaa and aba are not in the state space, T (a, aba) = aa.
3.2.4 Classification Method
The classification scheme contains the training phase and the testing phase. By
the end of the training phase, the algorithm has already learned the DPFA M+ and
M− for the “positive ECG signals” and “negative ECG signals” classes respectively.
Then to classify a given ECG signal g(t) from the testing dataset, we first symbolize
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the signal into a probabilistic string Pg, and then compare the goodness-of-fit between
Pg and M+ versus Pg and M−. The goodness-of-fit is measured using the expected
likelihood between word distributions.
3.2.4.1 The Word Distribution Defined by a DPFA
Let M = 〈Q,Σ, ε, P, T 〉 be a DPFA, then M defines a word distribution fM :
Σ∗ → R on the alphabet Σ by
fM(aj1aj2 . . . ajm) =
m∏
k=1
P (qk−1, ajk) (3.2)
for all non-empty aj1aj2 . . . ajm ∈ Σ∗ and fM(ε) = 1, where the state qk ∈ Q is defined
recursively by q0 = ε and qk = T (qk−1, ajk) (see Algorithm 4).
Algorithm 4 Word Distribution of a DPFA
Require: M = 〈Q,Σ, ε, P, T 〉 . DPFA




for k ← 1,m do
fM(w)← fM(w)P (q, ajk)
w ← wajk
q ← T (q, ajk)
end for
3.2.4.2 Compute Expected Likelihood
The expected likelihood EL(fP, fM) is defined as the expected value EfP [L(fM)]








which is computed with respect to the word distribution fP(w).
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The summation in (3.3) is well-defined as there are only finitely many words
w ∈ Σ∗ with fP(w) 6= 0 since P is a probabilistic string of finite length. As a measure
of goodness-of-fit, a greater value of expected likelihood implies a better fit between
the word distributions.
3.2.4.3 Classification
If EL(fPg , fM+) > EL(fPg , fM−), then the ECG signal g(t) is classified as “positive
ECG signal”, otherwise it is classified as “negative ECG signal”.
3.2.4.4 Implementation
The likelihood values L(fM±|w) can be calculated simultaneously with the word
distribution fPg(w) as the algorithm searches through all the words w ∈ Σ∗ until
fPg(w) = 0. Once the values L(fM± |w) and fPg(w) are found for all relevant w ∈ Σ∗,
one then applies formula (3.3) to compute the expected likelihoods EL(fPg , fM±).
The values EL(fPg , fM±) can be extremely small, which can lead to rounding
errors. Thus, log EL(fPg , fM±) is used instead of EL(fPg , fM±).
3.3 Arrhythmia and Event Annotation
Annotations of different types of arrhythmia are needed for using as labels in de-
tection and prediction experiments. Databases in DB1 has their own annotations,
most of them are annotated by clinicians. DB2 which is the retrospective database
collected in UMHS, does not have any annotations. We have designed an automated
annotation for different types of arrhythmia to encompass this difficulty. Continu-
ous ECG signals recorded with Bodyguardian for DB4 and DB5 are annotated by
Preventice’s own BeatLogic platform which is a commercially available FDA-cleared
system. The BeatLogic platform consists of 2 deep-learning models, BeatNet and
RhythmNet, the results of which are consolidated using rules-based logic to produce
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a single contiguous annotation file. We used Preventice’s annotation in DB4 and DB5
labels. The Preventice annotation included three types of AFib, AFib normal (heart
rate (HR) 60-100 BPM), AFib slow (HR < 60 BPM) and AFib rapid (HR > 100
BPM). All three types of AFibs for our analysis in DB4 and DB5 have been anno-
tated with Preventice with > 0.75 confidence. Please note that the AFib slow and
AFib normal might be less severe forms of AFib which were not included according
to our own annotations in DB2.
In the sections below, automated annotations are used and described below in
sections below for different types of arrhythmias used for labeling data in DB2.
3.3.1 AFib Annotation
To label the unannotated signals, annotation algorithms have been developed
based on the combination of heart rate and duration. Signals with extremely high
heart rate that last for a short period of time and signals with relatively lower heart
rate that last for a longer period of time are both considered to be indication for
symptomatic AFib. Using a single heart rate and duration might not capture all of
the symptomatic AFib events. Here we propose a heart rate-duration criteria region
in terms of a linear inequality that involves the values of heart rate recorded during
different duration periods.
3.3.1.1 AFib Annotation Algorithm
The annotation algorithm consists of 6 major parts: pre-processing of signal, R
peak detection, noise detection, heart rate and duration calculation, grid search on
combinations of heart rate and duration, and labelling signals according to the heart
rate-duration criteria:
1. During the signal pre-process step, we used a double median filter on the raw
ECG signals to remove baseline wandering and applied a Butterworth band
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pass filter to remove noises.
2. For R peak detection, we applied the Pan Tompkins algorithm for peak detection
Pan and Tompkins (1985).
3. Noise detection is performed by using 3 criteria. First, the percentage of missing
signal in a defined time window (set to 300s) is calculated, with the window be-
ing classified as noise if the missing signal percentage is above a certain threshold
(set to 15%). Secondly, if the signal passes the first criteria then we will check
for missing peaks by total variation analysis. Thirdly, if the signal passes both
the first and the second criteria, the third criteria will check if the percentage
of missing R peaks is above a certain threshold (set to 15%) in the current
window. The window of signal will be classified as noisy if it fails any of the
three criteria. Noisy signals will not be used for subsequent annotation.
4. Heart rate is calculated based on R peaks in a certain time interval. Duration
is calculated by counting the number of consecutive intervals that a particular
heart rate spans. The time interval is set to be 30 seconds and count up to 6
intervals, which gives us a range from 30 to 180 seconds.
5. A grid search on different combinations of heart rate and duration is performed,
for example using heart rates from 100 to 200 with an increment of 10 beats
at each step and duration from 30 to 180 with an increment of 30 seconds will
give us 66 different combinations.
6. Portions of signals with extreme high heart rate y2 that lasts for a short time
period x1 and a relative lower heart rate y1 that lasts for a longer time period x2
are both considered to be indication for symptomatic AFib. Using the straight
line passing through the points (x1,y2), (x2,y1), we check the heart rates between
durations x1,x2, if any of the heart rates on the duration grid is above the heart
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Figure 3.6: AFib annotation, an example of Heart Rate/Duration Criteria line goes
through (30,180) and (180,100).
rate-duration criteria line, that point of the signal is classified as symptomatic.
Figure 3.6 shows an example of Heart Rate/Duration Criteria line goes through
(30, 180) and (180, 100). If the heart rate/duration is satisfied by any of the
six red points in the grid search, it is classified as AFib.
This annotation method aggregates criteria found within the clinical literature for
severe cardiac events, and enables us to determine the cardiac events wherein a patient
will be considered symptomatic. However, it may not capture other cardiac events
that, though less severe, may still be predictive of severe events to come. As such,
for each type of cardiac event we wish to predict, clinician in our research team has
helped in both verifying the symptomatic criteria and identifying additional portions
of the ECGs that are indicative of the underlying event, but do not fall within the
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above criteria. This will enable the research team to annotate the relevant portions
of the collected waveforms, as will ensure that the predictions made by our algorithm
are correlated with true events.
3.3.1.2 Self-Reported Symptom Analysis
To better understand the relationship between symptoms and it’s effect on heart
rates, we have performed an analysis with patient’s self reported symptom data. Pa-
tients were monitored at home and asked to report the severity of multiple symptoms.
Five measurements are included: shortness of breath, fatigue level, palpitations, chest
pain and dizziness. We calculated a summary score z as the sum of these five mea-
surements and normalized the score for each individual: zi =
xi−min(x)
max(x)−min(x) . We then
extracted the maximum heart rate that occurred within 5 minutes before the time
that the symptom was reported and calculated the duration of that maximum heart
rate period. The objective of this experiment is to use maximum heart rate and its
duration to classify signals with high versus low symptom score z. The high symptom
score group consists of signals with z above the median of the normalized summary
score and low symptom score is defined as below the median of the normalized sum-
mary score. However, we did not find a clear correlation between symptomatic scores
and heart rate and duration. This may be due the unreliability of the self-reported
data, as different participants grade levels of discomfort and pain differently.
3.3.1.3 Literature Review
An extensive literature review has been conducted to identify severe AFib episodes.
AFib is defined by Calkins et al. (2012) to be a cardiac arrhythmia with three charac-
teristics: ’absolutely’ irregular RR intervals, no distinct P waves, and variable atrial
cycles of length < 200ms (> 300bpm).
An episode is considered significant when it lasts for at least 30 seconds January
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Table 3.1: The relationship between durations of AFib episodes and cardiovascular
health.
Duration of an AFib episodes Notes
30 seconds
Definition of AFib lasts for at least 30 seconds
ECG at least 30 seconds for accepted estimation of HR.
3 minutes
Considered as severe AFib episodes
by cardiologist in expert interview.
5 to 6 minutes Associated with increased risk of stroke.
5 minutes to >24 hours Associated with increased risk of stroke.
prolonged episodes of AFib Higher AFib density given same AFib burden
Figure 3.7: AFib annotation duration, a graphical depiction of the relationship be-
tween AFib duration and cardiovascular health.
et al. (2014), thus 30 seconds can be used as the lower limit for severe AFib in terms
of duration. AFib duration anywhere from 5 minutes to > 24 hours is associated
with increased stroke risk Passman and Bernstein (2016). Data from implantable
electronic cardiac devices also suggest that even relatively short AFib episodes (5-
6 minutes) are associated with an increased risk of stroke Passman and Bernstein
(2016). Given the same AFib burden, a patient with a small number of prolonged
episodes of AFib has a higher AFib density than a patient with many brief episodes
of AFib Passman and Bernstein (2016). Table 3.1 and Figure 3.7 demonstrate the
relationship between durations of AFib episodes and cardiovascular health.
In a nationwide community cohort of patients with permanent AFib, nearly all
patients had resting heart rate < 110 bpm (99%) and the majority (70%) were < 80
BPM. Atrial rates above a certain cut-off (typically 170–220 BPM) can be categorized
as atrial high rate episodes (AHRE). AHRE can be triggered by any of the atrial
tachyarrhythmias, including AFib, atrial flutter, or atrial tachycardia, with AFib
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Table 3.2: The relationship between heart rates of AFib episodes and cardiovascular
health
Resting Heart Rate Notes
80 bpm
Majority of participants with permanent AFib
70% were <80 bpm Steinberg et al. (2013).
100 bpm
CCS guidelines define the resting heart rate
target as <100 bpm, >100 bpm were associated
with adverse outcomes in AFFIRM and RACE trials Macle et al. (2016).
110 bpm
Nearly all participants had resting
heart rates <110 bpm (99%),
in a nationwide cohort with permanent AFib Macle et al. (2016).
Effective treating target for AFib Van Gelder et al. (2010).
170-220 bpm Categorized as atrial high rate episodes Shuai et al. (2016).
>180 bpm Severe AFib episode by cardiologist interview
and atrial flutter representing the most common arrhythmias Shuai et al. (2016). In
the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
study, adequate rate control was defined as < 80 bpm at rest, < 110 bpm on moderate
exertion (6-minute walk test), and average and maximal heart rates of < 100 bpm
and < 100% of age-predicted maximum, respectively, on 24-hour Holter monitor
Olshansky et al. (2004). The CCS guidelines define the resting heart rate target as <
100 bpm Macle et al. (2016); Andrade et al. (2017), the rationale being the observation
that resting heart rates> 100 bpm were associated with adverse outcomes in AFFIRM
and RACE. Table 3.2 and Figure 3.8 demonstrate the relationship between heart rates
of AFib episodes and cardiovascular health.
A criteria region is constructed for severe AFib episodes based on literature reviews
for HR and duration. Figure 3.9 below shows the suggested severe AFib region by
combining Figure 3.7 and Figure 3.2. Episodes less than 30 seconds of duration
are considered ’No AFib’, since 2014 ACA guideline defines AFib episodes to be 30
seconds and greater, also study suggests that ECG as least 30 seconds is needed for
accepted estimation of HR. HR below 80 is considered as no AFib, since it is well
below the treating targets for AFib (100 BPM). A linear line was selected using
duration-HR points (0.5 minutes, 180 bpm) and (5 minutes, 80 bpm). 180 bpm is
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Figure 3.8: AFib annotation heart rates, a graphical depiction of the relationship
between heart rate and severity of AFib.
chosen because it is our expert reviewed HR for severe AFib and 5 minutes is chosen
because increased risk for stroke is associated for duration > 5 minutes. The block
bounded by HR 80 to 180 bpm and duration 30 seconds to 5 minutes is separated
by the line in half. The upper triangle is considered more likely to be severe AFib
episodes, since higher HR and longer duration is associated with higher severity.
3.3.2 SVT Annotation
To make predictions of SVT episodes waveforms from patients diagnosed with
SVT required annotation, as some of the databases we have used are unannotated
databases. An SVT annotation algorithm with input from cardiologists has been
developed. The portions of signal annotated as SVT by our algorithm were then
used predict SVT events. For the pre-processing of the data we applied a fourth-
order Butterworth bandpass filter with cutoff at 0.5 and 40 Hz to the raw ECG for
noise removal, and a double median filter with orders 0.2 and 0.6 times the sampling
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Figure 3.9: AFib annotation, combining duration and heart rates
Assessing the severity of AFib at rest using a combination of heart rate and duration.
frequency to remove baseline wandering. We have also excluded the regions of the
signal that are too noisy for analysis. An automated annotation algorithm was applied
to determine SVT episodes with the ECG signal. Time windows consisting of three
R-R intervals were annotated as SVT if they satisfied all of the following four SVT
annotation criteria. First, an automated annotation algorithm based on the heart
rate-duration criteria line was used to annotate high heart rate events. Portions
of signals with extremely high heart rate y2 that last for a short time period x1,
and a relatively lower heart rate y1 that last for a longer time period x2, are both
considered to be indicative of high heart rate events. Using a straight line passing
through the points (x1,y2) and (x2,y1), the lower bound for heart rates in the criteria
region between duration x1 and x2 are determined. If any of the heart rates on the
duration grid are above the heart rate-duration criteria line, then that portion of the
signal lies in the criteria region and will be classified as high heart rate. In the case of
SVT, the episodes lie above the heart rate-duration criterion line passing through the
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points (30, 150) and (180, 100). Secondly, the difference between three consecutive
R-R intervals should be less than 50 ms. Thirdly, there should be fewer than 4 P/T
like waves within the window. Finally, the cross-correlations with the 500 P-wave
templates extracted from the MIT-BIH P-wave database should be less than 0.85.
A portion of the annotated SVT episodes were randomly selected and reviewed by a
cardiologist to confirm the sensitivity of the annotation algorithm.
3.3.3 VT Annotation
To make prediction on VT episodes in our databases, waveforms diagnosed with
VT required annotation. Two criteria were first applied to filter out the intervals
that might contain VT episodes. The first criterion is the heart rate should be above
100 bpm and the second criterion is average width corresponding to half length of
the peaks should be wider than 40 ms. The second criterion is defined because VT
episodes have wide QRS complex (> 120 ms), with half length of the peaks > 40 ms,
the width QRS complex will likely to be at least > 80 ms. This criterion is set to be
lower than the 120 ms, to make sure that we capture all the possible VT episodes for
manual review. The last step of VT annotation requires manual review by clinician
of the episodes which satisfied the 2 criteria.
3.3.4 Bradycardia Annotation
In order to extract bradycardia events that have more clinical importance, several
criteria were employed in terms of heart rate, medical diagnosis and medication.
1. Only the events with a heart rate of less than 60 BPM for 10 consecutive heart
beats were considered. 60 BPM was chosen because the National Institutes
of Health defines bradycardia as a heart rate < 60 BPM in adults other than
well trained athletes Kusumoto et al. (2019). Some studies and guidelines have
suggested to use < 50 bpm for the definition. We have chose < 60 bpm over
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< 50 bpm for because of first other additional criteria on co-morbidity and
medication have already been used filter the population, secondly with < 50
bpm there will be very limited bradycardia events for analysis (only 38 events
from 23 participants if < 50 bpm criteria was used). The choice of 10 consecutive
beats was made to eliminate short intervals of accidental low heart rate.
2. Patients without CHF were excluded. CHF makes the heart pump less effi-
ciently and effectively, thus causing symptomatic bradycardia.
3. The remaining population that satisfies both criteria is then separated according
to whether the patient is taking beta blockers or not. Beta blockers are a type
of medication used to manage abnormal heart rhythms including treatments of
tachycardia, myocardial infarction, CHF and other conditions. The effect of
beta blocker can result in a slower heart rate. The participants taking beta
blockers were excluded to eliminate low heart rates which were potentially due
to medication.
3.3.5 Activity Level
The raw accelerometer data are collected along three orthogonal axes in the device-
specific frame of reference. The continuous accelerometer data are collected using a
wireless monitoring device that adheres to patient’s chest (Preventice Solutions, Inc)
and sampled at 10 Hz. The accelerometer data were up-sampled to match the ECG
sampling rate. For the analysis, the accelerometer magnitude am(t) consisting of the
vector magnitude of the accelerometer data at each time point is used in analysis
together with the synchronized ECG signal.
am(t) =
√
x(t)2 + y(t)2 + z(t)2
= accelerometer magnitude at the time point t.
(3.4)
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The data is aggregated using mean amplitude deviation (MAD) which computes
the deviation of am(t) from its mean over the corresponding epoch, averaged over the









am(ti) = accelerometer magnitude at the ith time point
am = mean accelerometer magnitude within the time period of interest
n = length of the time period
The MAD ≤ 0.75 quantile relative to the measurements from the entire group
id designated as low activity and MAD > 0.75 quantile as high activity in order
to account for inter-individual differences in activity levels within the study group.
Threshold of 0.75 quantile for distinguishing activity levels is an arbitrary choice since
there is no well-established guideline for low vs. high activity level.
3.4 Pre-processing and Event Extraction
The aim of pre-processing is to remove noise from ECG signals. Methods focusing
on heartbeat segmentation within the ECG signal tend to require pre-processing Luz
et al. (2016). Automated annotation algorithms were used to annotate the arrhythmia
event and activity events as described in section 3.3.1. Pre-processing, noise removal,
and arrhythmia event extraction were performed in the same fashion for different
types of arrhythmia. The same pre-processing was applied to all methods in order to
make the results commensurable.
The following section describes the pre-processing and noise removal steps.
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3.4.1 Pre-processing
During the signal pre-processing step, a fourth-order Butterworth band-pass filter
with cutoff frequencies of 0.5 and 40 Hz is first applied to the raw ECG signal to
remove noise, after which a double median filter with orders equal to 0.2 and 0.6
times the sampling frequency is applied to remove baseline wandering. To calculate
heart rate and beat duration, the Pan–Tompkins algorithm for QRS detection is used
Pan and Tompkins (1985) Sedghamiz (2014).
3.4.2 Noise Removal
3.4.2.1 Noise Detection Algorithm 1
After R peak detection, a stepwise noise detection method is performed. There
are 3 criteria for noise detection. First, the method calculates the percentage of
missing signal in a defined time window (300 seconds) and checks if the missing
signal percentage is above a certain threshold (15%). If the percentage of the missing
signal is above the threshold, the signal is classified as being noisy by the first criteria.
Secondly, if the signal passes the first criterion then non-linear filter analysis is used
to determine missing peaks. If the signal passes both the first and the second criteria,
the third step determines if the percentage of missing R peaks is above a certain
threshold (15%) in the current window. The window of signal will be classified as
noisy if it fails any of these three criteria. Noisy signals will not be used for subsequent
annotation. Signals that occur too close to the noisy signal will also be excluded from
the analysis.
3.4.2.2 Noise Detection Algorithm 2
The ECG is then divided into time windows of 30 seconds each. R peaks are
found using the Pan-Tompkins algorithm Pan and Tompkins (1985). Three criteria
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are evaluated for each window based on cross-validated thresholds: high amplitude
artifacts, abnormal R peak distributions, and high amounts of distortion artifacts.
Distortion artifacts are characterized by clusters of critical points on the ECG curve.
Critical points are points on the ECG curve with a derivative of zero and an absolute
amplitude greater than 0.25 times the average R peak height within the window. A
high number of critical points indicates that the underlying waveform is hidden by
high frequency and high amplitude distortions that cannot be removed by simple
filtering.
3.4.3 Pre-event Signal Extraction
One of the aims of this study is to predict the onset of an cardiac event using
pre-event signals. In order to assess the predictive power of the method, events that
occurred too close to previous events were excluded, as the prediction interval should
not overlap with arrhythmia events. Events that occurred within defined length
of minutes of a noisy signal were also excluded, with the aim to ensure that the
prediction interval is out of the noisy signal range. Figure 3.10 shows an example
of an annotated ECG signal. After annotation, there is an annotated event A and
attendant prediction interval B, which is located tgap minutes before the annotated
event A with a length of tsignal minutes. The interval C classified as noise will be
excluded from the analysis, along with the neighboring intervals of defined length of
minutes.
In the prediction experiments, different combinations of tgap and tsignal for different
types of arrhythmia and cardiac events.
3.5 Comparison Method
In order to validate DPFA performance, several comparison algorithms have been
applied to the datasets. In most cases the algorithm outperforms the other more
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Figure 3.10: Prediction interval extraction.
Intervals of signal are extracted for use in prediction that are tgap minutes prior from the arrhythmia
event and several minutes away from detected noise.
traditional and well-established approaches, including a heart rate variability HRV
based method using SVM a method combining discrete wavelet transform (DWT),
PCA, a deep neural network (DNN), a CNN, and a CNN with LSTM.
Automatic detection of types of arrhythmia or cardiac conditions encompasses sev-
eral basic steps, including pre-processing/segmentation, feature extraction, followed
by a classifier Apandi et al. (2018). Machine learning (ML) approaches for arrhyth-
mia detection can be grouped into two main categories based on feature extraction
strategies Rizwan et al. (2020). The first group uses features extracted from the raw
ECG as input followed by classical ML algorithms such as SVM, KNN, and decision
trees as classifiers. Such ML algorithms require dimensionality reduction after fea-
ture extraction from the ECG signals. The second group uses raw ECG data as input
and does not require feature extraction. Information from the original physiological
signals can be directly processed by algorithms in this group Faust et al. (2020). ML
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algorithms like neural networks, including their basic and advanced versions, use the
raw data for model training and detection of arrhythmia types. Compared to the first
group, algorithms in this group generally have higher computational cost and require
larger datasets to achieve equal or greater performance. Our method belongs to the
second group, even though it is not based on neural networks.
In medical applications, datasets that are both sufficiently large and well-annotated
are not always available due to nature of the various diseases. Thus both groups have
their advantages and drawbacks. In this study we selected five methods from both
groups for comparison.
The first method is an SVM based arrhythmia classification algorithm with fea-
tures extracted from heart rate variability (HRV with SVM) by Asl et al. Asl et al.
(2008). Following Asl et al. (2008), time and frequency domain features were ex-
tracted from the signals. However, generalized discriminant analysis (GDA) for fea-
ture reduction was not utilized in this study since GDA would reduce the number of
features, and there are only two classes to begin with. The SVM model with radial
basis function (RBF) kernel was used for classification.
The second method for comparison uses the principal components of the DWT
coefficients as features and SVM as the classifier Martis et al. (2012).
The third comparison method is a DNN for arrhythmia prediction by Hannun
et al. (2019). The authors used a CNN to detect types of arrhythmia. The network
architecture has 34 layers, takes ECG signals as input and outputs arrhythmia classes.
The same experimental setup was used as in Hannun et al. (2019). The network was
trained de novo with random initialization and the Adam optimizer with default
parameters.
The fourth and the fifth comparison methods are both based on CNN techniques.
The fourth method, due to Acharya et al. (2017a), utilized a CNN algorithm to
automatically detect different ECG segments. The algorithm consists of an eleven-
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layer deep CNN. The fifth method, due to Tan et al. (2018), employed a LSTM (CNN
with LSTM) to classify ECG signals.
To compare the performance with alternative algorithms, the same training, cross
validation, and testing data sets were used.
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CHAPTER IV
Data Sources and Description
4.1 Introduction
A total of six databases have been constructed and collected for the project.
Database 1 (DB1) is comprised of several publicly available databases and has been
used for initial algorithm development. These are also benchmark databases that also
allow us to compare our algorithm with other existing methods. Database 2 (DB2)
is a retrospective database collected by UMHS, it containing previous UMHS car-
diac patients and non-cardiac control group. Clinicians have also reviewed DB2 and
annotated the waveforms, these annotations are the gold standard for classifying ar-
rhythmia types and can be used for further model training and prediction. Database
3 (DB3) is planned to be a prospective database that contains in-hospital data col-
lected from inpatients at UMHS. However, DB3 has not been collected due to patient
participation issues. Details about the collection difficulties can be found in section
4.4. Database 4 (DB4) consists of data collected from the patients after discharge,
at-home, in-vehicle and in other daily activities. DB4 contains data collected from
portable device and each participant has approximately 14 days of continuous ECG
data. Database 5 (DB5) contains data collected from healthy subjects, it serves a
control group. Each participant has approximately 7 days of continuous ECG data.
Database 6 (DB6) consists of a total of 45 patients with history of AF who presented
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Figure 4.1: Overview of databases, methods and prediction experiments.
to University of Michigan and are recruited in the study. The ECG and accelerometer
data were recorded continuously for up to 3 weeks. See Table 4.1 for a summary of the
characteristics of the databases and Figure 4.1 for an overview of databases, methods
and prediction experiments. Details of each database are described in sections below.
4.2 Database 1
DB1 is comprised of five external databases: PhysioNet/CinC 2017 Goldberger
et al. (2000), MIT-BIH Arrhythmia database Moody (1983), European ST-T Database
Taddei et al. (1992), PTB Diagnostic Database Bousseljot et al. (1995) , MIMIC-III
database Johnson et al. (2016). Among the five databases, PhysioNet/CinC2017,
MIT-BIH and European ST-T databases contain annotated signals. As the MIT-BIH
and European ST-T databases contain very few AFib patients and PhysioNet/CinC2017
consists only of isolated single episodes, all three databases are unsuitable for devel-
oping and testing for predictions. To have more data for supraventricular arrhythmia
and ventricular arrhythmia we have included three additional databases: MIT-BIH
supraventricular arrhythmia database Greenwald et al. (1990), MIT-BIH malignant
ventricular arrhythmia database Greenwald (1986) and Creighton university ventric-
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ular tachyarrhythmia Nolle et al. (1986). These three databases have annotations for
SVT and VT and we used them for testing our algorithm’s performance on SVT and
VT detections. See Table 4.2 for a summary of the databases we have used in papers
and manuscripts.
In performing AFib detection on the PhysioNet/CinC2017 database, we correctly
classified 84.2% AFib cases and 93.3% non-AFb cases in the testing set, with an F1
score of 0.74 and AUC of 0.95. For SVT detection, we correctly identified 41/56 SVT
events (0.73 sensitivity) and 97/100 (0.97 specificity) non-SVT events. The AUC is
0.951 and F1 of 0.914. Details about the SVT detection are in section 5.3.1.
For VA detection, we correctly identified 243/261 (0.93 sensitivity) VA episodes
and 227/261 (0.87 specificity) non-VA episodes for 5-seconds long signals, with an
AUC of 0.96 and F1-score of 0.91. For 2-seconds long signals, the algorithm correctly
identified 625/662 (0.94 sensitivity) VA episodes and 600/662 (0.91 specificity) non-
VA episodes with an AUC of 0.97 and an F1-score of 0.93. Table 4.3 below summarizes
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results based on DB1.
Arrhythmia prediction experiments were not tested in DB1, since most of the
recordings in the publicly available databases were of insufficient duration. DB1 was
mainly used for preliminary algorithm development, for prediction analysis we used
other databases. Details about the prediction analysis can be found in DB2, DB4,
DB5 and DB6.
4.3 Database 2
DB2 is a retrospective database containing previous UMHS cardiac patients and
a non-cardiac control group. It increases size of data for algorithm development and
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Table 4.3: DB1 Result summary for arrhythmia detection
Arrhythmia Sensitivity Specificity AUC F1
AFib Detection 0.84 0.93 0.95 0.74
SVT Detection 0.73 0.97 0.95 0.91
VA Detection 0.93 0.87 0.96 0.91
Table 4.4: Summary of DB2 by types of arrhythmia










training. One of our main objectives is to predict various types of arrhythmia. Length
of ECG is too short for predicting these events, DB2 on the hand has continuous
hospital bedside ECG recorded from cardiac patients. We used data for training the
prediction models.
The ECG waveforms in DB2 were collected from leads I, II, III and IV. There is a
total of 8838 waveforms from four leads from 1270 participants in DB2. Among these
8838 waveforms, there are 514 subjects with AFib episodes across 3540 waveforms.
The data quality is monitored by UM experts according to UM standards. A summary
of types arrhythmia contained in DB2 is shown in Table 4.4 below.
We have completed AFib prediction analysis, SVT prediction analysis and VT
prediction using DB2 with the DPFA algorithms. Our own annotation algorithms for
AFib, SVT and VT were applied to the waveforms in DB2 and used for classifying
events. For AFib predictions, the AUC is above 0.85 for all 2-minute long prediction
intervals. Prediction performances with 2-minute long signals are slightly better than
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1-minute long and 0.5-minute long signals. For the SVT prediction analysis, we
examined the predictive power of the DPFA algorithm with different pre-SVT lengths.
The AUC is above 0.80 for all 2 minute-long prediction intervals. As the time to
the SVT event increases, the mean prediction performance gradually declines while
variance increases. The AUC for VT prediction is around 0.75, which are not as
good as other types of arrhythmias like AFib or SVT. The lack of performance might
be due to the low number of participants having VT compared to other arrhythmia
types. Details about the prediction results can be found in sections in Chapter 6.
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4.4 Database 3 and Database 4
4.4.1 Database Construction Challenges
Database 3 (DB3) is planned to be a prospective database that will contain in-
hospital data collected from current inpatients at UMHS. It will contain continuous
ECG, blood pressure and patient clinical data. Database 4 (DB4) consists of a subset
of patients that will be included in DB3 with data collected after discharge, at-home
and during daily activities including driving. Prior to the start of patient recruitment,
several changes were made to the study protocol including the removal of the required
sensor, the addition of the blood pressure cuff, and recruiting from the Cardiovascular
Center (CVC) ICU instead of from the Emergency Department.
The purchase of additional devices required for the study was delayed. These
were later resolved and the devices were approved for purchase after which patient
recruitment started. However, the aforementioned recruitment strategy resulted in a
number of challenges for both databases. For potential patients planned to include in
DB3, due to their illness many of these patients were intubated and/or sedated and
were thus unable to consent to in-hospital monitoring. Additionally, the severity of
their illnesses curtailed patient interest in study participation. Due to these patient
participation concerns, DB3 has not been collected as planned.
There were numerous challenges for recruiting patients for the at-home database
DB4 as well. Many patients who were discharged from the CVC ICU had recently
closed wounds on their chests as a result of recent surgery. These wounds prevented
them from wearing the BodyGuardian monitor. Other potential patients were pre-
scribed a separate at-home monitor for clinical use, which prevented them from wear-
ing the BodyGuardian monitor. Finally, as UMHS serves as a regional referral hos-
pital, many patients lived two or more hours away, and were unwilling to travel back
to Ann Arbor to return equipment. These challenges resulted in only one study
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participant being successfully recruited from the CVC ICU.
In order to resolve these aforementioned recruitment issues, we revised our re-
cruitment strategy in consultation with our study coordinator and clinician. Rather
than recruiting from the CVC ICU, where patients meet our inclusion criteria with
respect to relevant arrhythmias but are often too sick to be recruited, we have been
recruiting patients who use the services provided by the CVC Device Clinic.
The CVC Device Clinic services patients with pacemakers, ICD, and other cardiac
equipment. These patients are at risk of developing life-threatening arrhythmias such
as severe AFib or SVT, VFib, and VT, making them ideal subjects for our study.
For Databases 3 and 4, 66 patients have been enrolled, 11 patients have exited the
study early or have no data. A total 55 patients have completed the study and have
data from BodyGuardian devices. Although we have enrolled less participants than
originally planned in the, each participant has a much longer monitoring time. For
each subject that completed the study we have approximately 14 days of continuous
ECG data compared to 3 - 4 days as planned. Table 4.6 below shows number of
participants with different diagnosis in DB4.
We have completed AFib prediction analysis, SVT prediction analysis using DB4
with the DPFA algorithms. Preventice annotation algorithm For AFib predictions,
the AUC is around 0.71 for various prediction intervals. For the SVT prediction
analysis, we examined the predictive power of the DPFA algorithm with different
pre-SVT lengths. The AUC is above 0.75 - 0.88 for various prediction intervals. As
the time to the SVT event increases, the mean prediction performance gradually
declines while variance increases.
4.5 Database 5
Database 5 consists with healthy control participants for the study. Similar to
DB4, participants in DB5 have data collected with Bodyguardian devices provided
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Table 4.6: Patients in Database 3 and Database 4 by diagnosis
Diagnosis Number of Participants
AFIB 9







Implantable cardiac monitor/ complete heart block 1
Non-ST elevation myocardial infarction 1







Wolff Parkinson white 1
by Preventice. A total of 80 subjects have been enrolled as planned, with 74 having
completed data collection. For each subject that completed the study we have ap-
proximately 7 days of continuous ECG data which is much longer than what we have
planned (2-3 hours each).
Table 4.7 below shows a summary of recorded time in DB4 and DB5. There is a
total of 721 ECG recorded over 13963 hours in DB4 and a total of 555 ECG recorded
over 10307 hours in DB5. 26328 AFib events for total of 364 hours are recorded in
DB4 and 348 AFib events over a total of 7 hours are recorded in DB5 with Preventice
annotations. Among the 55 participants in DB4, 16 of them had AFib events during
driving. There is a total of 13963.5 hours ECG recording time in DB4, with 873.7
(6.26%) hours of them recorded in vehicle. There is a total of 363.5 hours of AFib
recorded in DB4, with 16.4 (4.51%) hours of them recorded in vehicle. So there is
no evidence suggesting more AFib were recorded in vehicle. A total of 532 hours of
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Table 4.7: Summary of recorded ECG time
DB4 DB5
Total number of ECG 721 555
Total ECG time (hrs) 13963.53 10306.73
Total number of AFib events 26328 348
Total AFib time (hrs) 363.52 7.56
Total Normal Sinus time (hrs) 4646.21 6201.41
Total in-vehicle AFib time (hrs) 16.41 0.01
Total in-vehicle time (hrs) 873.73 532.13
in-vehicle time is recorded in DB5, only 0.01 hours of AFib time is observed which is
expected since DB5 is the control group.
4.6 Database 6
Database 6 (DB6) consists a total of 45 patients with history of AF who presented
to University of Michigan are recruited in this database. All patients wore an event
recorder (Preventice solutions Inc) for up to three weeks. IRB approved the protocol
and written informed consent was obtained. The ECG and accelerometer data were
recorded continuously for up to 3 weeks. DB6 is used for prediction analysis of RVR
with low levels of activity, 18 participants are included in the prediction analysis.
Table 4.8 describes the patient characteristics of DB6.
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Participants in Prediction Analysis
(n=18)
Female 14 (31.82%) 5 (27.78%)
Age 66.36 (11.67%) 69.13 (7.31%)
BMI 31.30 (6.08%) 30.93 (5.66%)
Hypertension 26 (59.09%) 11 (61.11%)
History of Stroke 0 (0.00%) 0 (0.00%)
Diabetes 12 (27.27%) 5 (27.78%)
Coronary artery disease 11 (25.00%) 5 (27.78%)
Peripheral vascular disease 2 (4.54%) 2 (11.11%)
Beta Blockers 31 (70.45%) 13 (72.22%)
Calcium channel blockers 14 (31.82%) 4 (22.22%)





This chapter presents the results for the experiments on the detection and predic-
tion of different types of arrhythmia and cardiac events followed by discussion and
limitation sections. The experiments include AFib detection based on DB1 with pub-
licly available databases, AFib prediction based on DB2 with hospital bed-side data
and DB4 and DB5 for data collected from portable devices and during driving; SVT
detection based on DB1 with publicly available databases, SVT prediction based on
DB2 with hospital bed-side data and DB4 and DB5 for data collected from portable
devices; VA detection based on DB1 with publicly available databases, VT prediction
based on DB2 with hospital bed-side data; Bradycardia prediction based on DB2 with
hospital bed-side data and RVR with low activity prediction based on data collected
on DB6 from portable devices.
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5.2 Atrial Fibrillation
5.2.1 AFib Detection on Benchmark Datasets
5.2.1.1 Data
PhysioNet/Cinc2017Goldberger et al. (2000) described in Section 4.2 was used
to help develop the algorithms. The dataset contains 738 AFib episodes and 7790
non-AFib episodes consists with normal, noisy or other episodes.
5.2.1.2 Method
Encoding and peak detection algorithms are applied to produce a training peak
probability vector for AFib cases and a training peak probability vector for non-AFib
cases. The DPFA algorithm is then applied to the training probability vectors to
obtain the transition matrices.
Encoding and peak detection algorithms are applied to the testing data to produce
a testing probability vector. By applying the results from AFib DPFA output and
non-AFib DPFA output to the testing probability vector, we can get a probability
matrix for AFib and non-AFib.
We take the logarithmic average of the two probability vectors and compare the
two results. The class with the higher average of the probability will be the predicted
class. The predicted class is then tested against the ’true’ label. The method is
described in Section 3.2.
5.2.1.3 Result
Two DPFA models are computed from the dataset:MA for class ’AFib’ with 5892
states and MN for class ’Other’ with 117058 states. We have correctly classified 84.2%
of AFib cases and 93.3% of non-AFib cases in the testing set with an F1 score of 0.74
and AUC of 0.95. The results are shown in Table 5.1 and Figure 5.1.
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Table 5.1: AFib detection results on publicly available benchmark datasets
Class Classfied as ”AFib” Classified as ”Non-AFib” Accuracy
AFib 80 15 84.2%
Non-AFib 61 844 93.3%
Figure 5.1: AFib detection, ROC curve for AFib detection on publicly available
benchmark datasets (DB1).
Publicly available benchmark databases were used for algorithm development for
earlier stage of the study. The result has validated the possibility of using DPFA
algorithm to predict AFib events.
5.2.2 AFib Prediction on Hospital Bedside Dataset
Experiments for AFib predictions are performed on DB2 which consists of hos-
pital bedside data, Methods, result and discussion for AFib prediction with hospital
bedside dataset are described in details in sections below .
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5.2.2.1 Data
A retrospective database with ECG signals from Michigan Medicine cardiac pa-
tients with AFib was used in this study. After excluding recordings with pacemakers,
implantable cardioverter defibrillators (ICD), or ventricular assist devices (VAD),
there were 1210 lead II ECG recordings for patients with AFib. The recordings were
sampled at 240 Hz. Details about this dataset is described in Section 4.3.
5.2.2.2 Method
DB2 consists of data collected from hospital bedside and is used for prediction
experiment. DB2 does not have annotation, thus an automated annotation algorithm
has been developed to annotate the events with a combination of heart rate and
duration. Heart rate is calculated based on the R peaks within a time interval, which
were detected previously during test interval extraction. Duration is calculated by
counting the number of consecutive intervals that a particular heart rate spans. For
this study, the time interval was set to 30 seconds and counted up to 6 intervals,
which allows for the duration to range from 30 to 180 seconds.
The automated annotation algorithm based on the heart rate-duration criteria
region is described in detail in Section 3.3.1 to annotate AHRE events with different
heart rate and duration limits. The lower duration limit of 30 seconds is chosen in
accordance with the definition of an AFib event provided by the 2014 AHA guideline
January et al. (2014). The lower heart rate limit is set to 110 bpm, as this rate has
proven to be an effective treatment target for AFib Van Gelder et al. (2010). The
higher heart rate limit is set at 160 bpm since a rapid heart rate is more likely to
cause symptoms.
Rapid heart rate in AFib may also have an untoward effect on cardiac function,
resulting in tachycardia-induced cardiomyopathy Fuster et al. (2006). Using this
annotation method, it becomes possible to capture the portions of the signal that
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Figure 5.2: AFib prediction, data partitioning scheme used for AFib prediction in
hospital bedside database (DB2).
correspond to AHRE with sufficiently high severity, either in the form of extremely
high heart rate over a span of 30 seconds, or moderately high heart rate stretching
over 180 seconds. A heart rate-duration criteria region that lies above the line pass-
ing through the points (30, 160) and (180, 110) is used. These AHRE events were
annotated as surrogate for AFib.
A total of 417 AFib events were labeled by these criteria and a total of 7319 non-
AFib intervals were randomly selected from non-AFib regions of the signals. A total
of 353 of the AFib intervals were used in training with the remaining 64 intervals
being held out for testing. Within the training data set, 5-fold cross validation was
performed for parameter tuning (Figure 5.2). Training, cross validation, and testing
sets/folds were partitioned on a participant level, meaning that signals from the same
participant were only included in one set/fold so as to prevent over-fitting.
The five models (each with four folds of training data) with the best parameters
tuned during cross validation were then applied to the testing set.
5.2.2.3 Result and Discussion
Different combinations of signal intervals (i.e., tsignal = 0.5, 1.0, 2.0 minutes) and
gap intervals (i.e., tgap = 0.5, 1.0, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5 minutes) up to 5 minutes
prior to the event were used for prediction. These prediction intervals were tested
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using the DPFA algorithm. Figure 5.3 depicts a summary of the performance. For the
AHRE DPFA, around 758× 3, 683× 3, and 582× 3 transition states were generated
for 0.5, 1.0 and 2.0-minute long AHRE prediction intervals based on the training data
set. For the non-AHRE, an average of 626 × 3 transition states were generated for
the models using 0.5-minute long signals, 642×3 transitions states for the 1.0-minute
long signal models, and 459×3 transition states for the 2.0-minute long signal models.
The AUC is above 0.80 for all prediction intervals. Performance is nearly steady
when gap length increases and the prediction interval moves further away from the
AHRE events. Prediction performances with 2-minute long signals are slightly better
than 1-minute long and 0.5-minute long signals (Figure 5.3). Longer signals contain
more local and global patterns and these information may have contributed to the
better performances.
The performance of DPFA on raw ECG data was compared with its performance
on data with pre-processing (Figure 5.3). The AUCs for prediction intervals are al-
most the same with or without pre-processing. Nor is there any statistically significant
difference between these results.
For AHRE prediction, the DPFA algorithm has a comparable performance to deep
learning with on average a 2% higher AUC. For the other comparison algorithms,
DPFA has a 17.9% higher AUC than HRV, 26.1% higher AUC than DWT, 15.4%
higher AUC than CNN and 10.3% higher AUC than CNN with LSTM. The results
for these experiments are shown in Figure 5.4.
The McNemar test was also performed to evaluate the performance of the alter-
native methods against the proposed DPFA algorithm. The McNemar test used a
1:11 ratio for the cost for the imbalance of data. Tables 5.2, 5.3, and 5.4 depict the
results for half-minute, 1-minute, and 2-minute long signals with various gap sizes,
respectively. p-values representing the statistical significance of the different perfor-
mance in terms of AUC (< .05) are shown in bold font in the referenced tables. The
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Figure 5.3: AFib prediction on hospital bedside database (DB2), A comparison of
AUC for AHRE prediction using the DPFA with and without pre-processing method
for various signal lengths and gap intervals.
57
Figure 5.4: AFib prediction on hospital bedside database (DB2), A comparison
of AUC for AHRE prediction for all models using various signal lengths and gap
intervals.
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Table 5.2: AFib prediction on hospital bedside database (DB2), a comparison of






































































































































































































deep learning algorithm has no statistically significant difference in performance with
respect to the McNemar test. However, the DPFA algorithm has 40.1% lower vari-
ance than deep learning. On the other hand, HRV, CNN and DWT have much lower
AUC. The results for HRV with SVM were obtained after further excluding certain
cases. Two AHRE cases and 20 of control cases were excluded from the test dataset
because peak annotation could not be correctly applied to the signals. Although CNN
with LSTM has lower AUC than the DPFA model, there is no significant difference in
the McNemar test results for 1-minute and 2-minute long signals. CNN with LSTM
performs better than the CNN model.
5.2.3 AFib Prediction with Data Collected from Portable Devices
5.2.3.1 Data
In this experiment, analysis for AFib prediction was performed with data collected
from portable devices, (DB4 and DB5). Details about DB4 and DB5 are described
in details in Sections 4.4 and 4.5. For DB4 and DB5, the AF events were anno-
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Table 5.3: AFib prediction on hospital bedside database (DB2), a comparison of AUC




















































































































































































Table 5.4: AFib prediction on hospital bedside database (DB2), a comparison of AUC

















































































































































tated using the FDA-cleared BeatLogic algorithm. Preventice BeatLogic platform, a
comprehensive ECG annotation platform that leverages deep learning for beat and
rhythm detection/classification Teplitzky et al. (2020).
5.2.3.2 Result and Discussion
Four sets of analyses were performed on the patient population:
• AFib only (participant number=9, event number=70)
• AFib with or without other arrhythmia (participant number=12, event num-
ber=303)
• all types of arrhythmia (participant number=55, event number=589)
• DB4 and DB5 (participant number=129, event number=654)
Details about the patient diagnosis are described in Table 4.6. The AUC for all
arrhythmia group is around 0.71-0.73. The AUC for the AFib only group ranges
from 0.65-0.69 which is lower than the all arrhythmia group. This might be due to
the lower number of patients and episodes in the AFib only group. The AUC for the
AFib with/without other arrhythmia group ranges from 0.61-0.65. The lower AUC
in this group is due to these patients having AFib with other morbidities like VT or
Vfib. The AUC for DB4 and DB5 combined has lower performance than DB4 only.
We might need to further examine the events annotated in DB5, since it is the control
group with healthy patients. The experiment results of these analysis are depicted in
Table 5.5, Figures 5.5, 5.6, 5.7 and 5.8, which show the achieved AUC for different
arrhythmia populations.
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Figure 5.5: AFib predictions on data collected from portable devices (DB4, DB5),
AUC for AFib events prediction, AFib only (n=9).
62
Figure 5.6: AFib prediction on data collected from portable devices (DB4, DB5),
AUC for AFib events prediction, All AFib (n=12).
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Figure 5.7: AFib predictions on data collected from portable devices (DB4, DB5),
AUC for AFib events prediction, All Arrhythmia (n=55)
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Figure 5.8: AFib predictions on data collected from portable devices (DB4, DB5),




























































































































































































































































































































































































































































































Table 5.5: AFib predictions on portable devices dataset (DB4, DB5), results sum-
mary for AFib events prediction on DB4 and DB5.
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5.2.4 AFib Prediction on In-vehicle Data
5.2.4.1 Data
Driving logs were collected from each study participant and were used to determine
the portion of collected ECG signals that were recorded in-vehicle. In the analysis
presented in this section, predictions were made on the annotated AFib events that
occurred during the in-vehicle time periods only. There is a total of 35 annotated
AFib episodes in all types of arrhythmia during driving from 7 patients. A total of
874 hours of in-vehicle time is recorded in DB4 with observing AFib evetns over 16
hours. A total of 532 hours of in-vehicle time is recorded in DB5, only 0.01 hours of
AFib time in DB5 as described in Table 4.7.
5.2.4.2 Result
Figure 5.9 and Table 5.9 below shows the performance in AUC for all arrhythmia
participants during driving. The performance of the algorithm on the in-vehicle only
dataset in AUC is very similar to AUC for the entire group. The 2-minute prediction
is lower than before; however the standard deviation for the 2-minute predictions are
also very large. This could be due to the low number of patients and events in this
analysis. We expect the performance to improve with more driving events.
5.3 Supraventricular Tachycardia
SVT detection and prediction experiments were performed on various databases.
DB1 is constructed from publicly available databases and used for SVT detection
experiment. In DB1, we have correctly identified 41/56 SVT events (0.73 sensitivity)
and 97/100 (0.97 specificity). The AUC is 0.951 and F1 of 0.914. DB2 is a retro-
spective database from UMHS and used for SVT prediction experiment. There is a
total of 139 subjects with SVT diagnosis, 38 of them have SVT episode met with
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Table 5.6: AFib predictions on in-vehicle dataset (DB4, DB5), summary of results














0.5 0.5 0.704 (0.011) 0.668 (0.026)
1 0.5 0.709 (0.014) 0.673 (0.022)
1.5 0.5 0.720 (0.014) 0.659 (0.031)
2 0.5 0.726 (0.013) 0.659 (0.029)
2.5 0.5 0.715 (0.020) 0.671 (0.004)
3 0.5 0.726 (0.024) 0.658 (0.010)
3.5 0.5 0.717 (0.028) 0.660 (0.013)
4 0.5 0.713 (0.004) 0.659 (0.014)
4.5 0.5 0.690 (0.016) 0.662 (0.008)
0.5 1 0.668 (0.040) 0.657 (0.030)
1 1 0.666 (0.039) 0.657 (0.031)
1.5 1 0.680 (0.005) 0.653 (0.027)
2 1 0.684 (0.006) 0.650 (0.024)
2.5 1 0.704 (0.007) 0.642 (0.019)
3 1 0.702 (0.012) 0.650 (0.028)
3.5 1 0.683 (0.005) 0.646 (0.028)
4 1 0.663 (0.033) 0.645 (0.015)
0.5 2 0.611 (0.126) 0.682 (0.041)
1 2 0.642 (0.128) 0.672 (0.040)
1.5 2 0.645 (0.129) 0.674 (0.030)
2 2 0.645 (0.122) 0.672 (0.037)
2.5 2 0.648 (0.112) 0.678 (0.032)
3 2 0.637 (0.115) 0.671 (0.038)
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Figure 5.9: AFib predictions on in-vehicle dataset (DB4, DB5), AUC for AFib events
prediction, in-vehicle only (n=7).
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annotation criteria as in Section 3.3.2. DPFA algorithm is applied for SVT predic-
tion with various prediction intervals and achieved an AUC greater than 0.75 for all
prediction intervals in DB2. DB4 contains participants diagnosed with various types
of arrhythmia while DB5 is the control group. There is a total of 27 SVT events that
met annotation criteria from 12 patients from DB4 included in the analysis. Non-
SVT events were randomly selected from all DB4 and DB5 episodes. The prediction
AUC values are in the range of 0.79-0.87 for DB4 and 0.78-0.92 for DB4 and DB5
combined. SVT predictions while in-vehicle experiment was not performed due to
the limited data size.
5.3.1 SVT Detection on Benchmark Datasets
5.3.1.1 Data
Three publicly available benchmark datasets in DB1 with SVT rhythm anno-
tations were used in this study. The first dataset was the MIT-BIH Arrhythmia
Database (mitdb) Goldberger et al. (2000), which contains 48 half-hour excerpts of
two-channel ambulatory ECG recordings, obtained from 47 subjects enrolled in the
study. The recordings were sampled at 360 per second. Two or more cardiologists
have independently annotated each recording. The second database was the long-
term AFib database (ltafdb) from physionet Goldberger et al. (2000); Petrutiu et al.
(2007). This database includes 84 long-term ECG recordings of subjects with parox-
ysmal or sustained atrial fibrillation (AF). Each recording contains two simultane-
ously recorded ECG signals sampled at 128 Hz with duration around 24 to 25 hours.
The third database was the MIT-BIH Malignant Ventricular Arrhythmia Database
(vfdb) Goldberger et al. (2000) sampled at 250 Hz. All three databases contain some
annotated SVT episodes other than AFib or atrial flutter.
Episodes of SVT were extracted from the three databases based on the rhythm
annotations. These SVT episodes were then separated into 10-second-long segments.
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We aim to detect these SVT events based only on the data contained within 10-
second-long intervals.
There was a total of 667 10-second intervals. Among these episodes 611 were
included in the training set and the remaining 56 episodes from a different patient
cohort were reserved for the testing set. Additionally, 800 of the non-SVT episodes
were randomly selected for the training set and 100 of non-SVT episodes were selected
for the testing set.
5.3.1.2 Method
Heart Rate Variability with Machine Learning Techniques is described in the sec-
tion below. Apart from the DPFA algorithm as described in Section 3.2, an algorithm
based on heart rate variability (HRV) was used as comparison. This section will de-
scribe the algorithm.
During the signal pre-processing step, a fourth-order Butterworth bandpass filter
with cutoff frequencies at 0.5 and 40 Hz was first applied to the raw ECG signal to
remove noise, after which a double median filter with orders equal to 0.2 and 0.6
times the sampling frequency was applied to remove baseline wandering.
The signals from mitdb or vfdb were then down-sampled to 128 Hz to be consistent
with ltafdb.
Episodes of SVT were extracted from the three databases based on the rhythm
annotations. These SVT episodes were then separated into 10-second-long segments.
The R-peaks and QRS complex were detected by the Pan–Tompkins algorithm
Pan and Tompkins (1985) Sedghamiz (2014). After identifying the R-peaks and QRS
complex, we extracted a total of 16 features from the 10-second intervals as shown in
Table 5.7.
Several machine learning algorithms including random forest (RF), support vector
machine (SVM), and k-nearest neighbors (KNN) on the training dataset with 5-fold
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Table 5.7: SVT detection, HRV features extracted for SVT detection on publicly
available benchmark datasets (DB1)
HRV features Description
ApEn
Approximate entropy, which measures the
regularity and complexity of a time series
HR Mean heart rate
SDHR Standard Deviation of heart rate
RR Mean RR interval
SDRR Standard deviation of RR intervals
CV RR
SDRR/meanRR intervals unitless scaled
with factor 100
QS Mean Q-S peak interval
SDQS Standard deviation of Q-S peak interval
NN50
pairs of adjacent RR intervals differing that
differ by more than 50 ms
pNN50
Percentage of successive RR intervals that
differ by more than 50 ms
RMSSD
Root mean square of successive RR
interval differences
SDSD
Standard deviation of differences between
adjacent RR intervals
Poincaré SD1
Poincaré plot standard deviation perpendicular
the line of identity
Poincaré SD2




Number of points (dRR(i-1),dRR(i)) within the
radius normal sinus rhythm mask
Lorentz
OriginCountRatio
Ratio between number of points (dRR(i-1),dRR(i))
within the radius normal sinus rhythm mask
cross validation. The cross validation procedure was performed on the training dataset
only, enabling parameter optimization with respect to area under ROC curve (AUC)
performance.
Among the three methods, RF seemed to have achieved the best result on the
training dataset (Figure 5.10).
Among the 16 HRV features, mean QS interval length, Poincaré SD2, mean RR
interval and mean HR had the highest importance based on the trained random forest
algorithm on the training dataset. Importance was calculated as the weighted average
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.
Figure 5.10: SVT detection on publicly available benchmark datasets, comparison
of machine learning algorithms on training data
of the differences between the prediction accuracies on the out-of-bag portion or the
entirety of the data. Regression was performed based on the weighted average of the
differences of the respective MSEs instead.
The RF model with the best AUC based on the training data was then applied
on the testing data for evaluation.
DPFA model was applied for SVT detection with a binary encoding. Details of
the algorithm can be found in Section 3.2.
5.3.1.3 Results
The result section begins by showing the algorithms’ ability to detect annotated
SVT episodes using HRV features and RF. Then we will also show the performance
of the DPFA for SVT detection.
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Figure 5.11: SVT detection on publicly available benchmark datasets, variable im-
portance on training data
.
There was a total of 667 10-second intervals. 611 of these episodes were included
in the training set and the remaining 56 episodes from a different patient cohort
were reserved for the testing set. The algorithm correctly classified 51 out of 56
SVT episodes with sensitivity of 91.1% and 100 out of 100 non-SVT episodes with
specificity of 100% in the testing set. The F1 score was 0.95 and the AUC was 0.995.
The results are described in Table 5.8 and Figure 5.12.
With the DPFA algorithm, we have correctly identified 41/56 SVT events (0.73
sensitivity) and 97/100 (0.97 specificity). The AUC was 0.951 and F1 score was 0.914.
Results are summarized in Table 5.9.
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Table 5.8: SVT detection on publicly available benchmark datasets, confusion matrix





SVT 51 0 51
Non-SVT 5 100 105
Total 56 100 156
Figure 5.12: SVT detection on publicly available benchmark datasets, ROC curve for
SVT Detection with HRV features and RF.
5.3.1.4 Discussion
In this part of the study, HRV features with RF successfully detected the SVT
episodes with 0.995 AUC and 0.95 F1 score. The DPFA algorithm was able to detect
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Table 5.9: SVT detection on publicly available benchmark datasets,,confusion Matrix





SVT 41 3 44
Non-SVT 15 97 112
Total 56 100 156
the SVT episodes with high AUC of 0.95 and F1 of 0.91. The performance of the HRV
features with RF is better than the DPFA algorithm. However, the DPFA algorithm
does not require calculation of hand-crafted features and can be applied easily on
real-time data collected from portable devices the DPFA algorithm is expected to
perform better with a larger dataset with more complex morphologies in signals.
One limitation of the study is the lack of annotated samples with good quality
labels. There are more databases with beat to beat annotations but not many of
them has rhythm labels. Without these rhythm labels it is hard to classify different
types of arrhythmia other than the beat types. We used the three publicly available
databases with well annotated rhythms, however the number of SVT episodes we
obtained from these records were still rather low. With limited amount of samples,
the trained DPFA and RF model are more prone to problems such as generalizability
and whether they can be directly applied to other datasets. Although in the testing
set, we tested the algorithms on a different patient population, more ECG data with
quality SVT labels are required to further validate the programs.
5.3.2 SVT Prediction on Hospital Bedside Dataset
5.3.2.1 Data
DB2 is used for SVT prediction. It is a retrospective database with ECG signals
from Michigan Medicine cardiac patients with SVT. After excluding recordings with
pacemakers, implantable cardioverter defibrillators (ICD), or ventricular assist devices
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(VAD), there were 181 lead II ECG recordings for patients with SVT. Details about
DB2 can be found in Section 4.3.
5.3.2.2 Method
After pre-processing and noise removal as described in Section 3.3.2, an automated
annotation algorithm was applied to determine SVT episodes with the ECG signal.
Time windows consisting of three R-R intervals were annotated as SVT if they satis-
fied all of the following four SVT annotation criteria. First, an automated annotation
algorithm based on the heart rate-duration criteria line was used to annotate high
heart rate events. The annotation criteria region is described in detail in Section
3.3.1. In the case of SVT, the episodes lie above the heart rate-duration criterion line
passing through the points (30, 150) and (180, 100). Secondly, the difference between
three consecutive R-R intervals should be less than 50 ms. Thirdly, there should be
fewer than 4 P/T like waves within the window. Finally, the cross-correlations with
the 500 P-wave templates extracted from the MIT-BIH P-wave database should be
less than 0.85.
A total of 149 SVT events were annotated by the algorithm and a total of 755
non-SVT intervals were randomly selected from the non-SVT regions of the signals.
A total of 119 (80%) of the SVT intervals were used in training with the remaining 30
intervals being held out for testing. Within the training data set, 5-fold cross valida-
tion was performed for parameter tuning (Figure 5.2). Training, cross validation, and
testing sets/folds were partitioned on a participant level, meaning that signals from
the same participant were only included in one set/fold so as to prevent overfitting.
The five models (each with four folds of training data) with the best parameters
tuned during cross validation were then applied to the testing set.
Parameters are tuned with training and validation data as described in Section
3.2.2, the optimal parameters are listed in 5.1.
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The performance of DPFA model were compared with five comparison methods
described in Section 3.5. The McNemar test used a 1:5 ratio for the cost for the
imbalance of data.
5.3.2.3 Results
Different combinations of signal intervals (i.e., tsignal = 0.5, 1.0, 2.0 minutes) and
gap intervals (i.e., tgap = 0.5, 1.0, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5 minutes) up to 5 minutes
before the event were used for prediction. These prediction intervals were tested
using the DPFA algorithm. Figure 5.13 shows a summary of the performance. The
AUC is above 0.75 for all prediction intervals. As the time to the SVT event increases,
the mean prediction performance gradually declines while variance increases. For the
SVT DPFA, an average of 114 × 3 transition states were generated for the models
using 0.5-minute long signals, 97× 3 transitions states for the 1.0-minute long signal
models, and 60 × 3 transition states for the 2.0-minute long signal models. For the
non-SVT DPFA, an average of 114×3 transition states were generated for the models
using 0.5-minute long signals, 95× 3 transitions states for the 1.0-minute long signal
models, and 56× 3 transition states for the 2.0-minute long signal models.
The performance of the DPFA on raw ECG data was compared with its perfor-
mance on pre-processed data (Figure 5.13). The AUC for all prediction intervals are
almost the same with or without pre-processing and there is no statistically signifi-
cant difference between these results. These results indicate that pre-processing does
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not impact the performance of the DPFA algorithm.
The proposed DPFA algorithm has on average a 10.2% higher AUC than the deep
learning method, 32.9% higher than DWT with PCA, 33.3% higher than CNN and
26.4% higher than CNN with LSTM for various prediction intervals. The HRV with
SVM algorithm has comparable performance on SVT prediction, with a slightly lower
average AUC compared to DPFA. Figure 5.14 summarizes the performance of DPFA
together with the 5 alternative methods. The McNemar test was also performed
to evaluate the performance of the alternative methods against the proposed DPFA
algorithm. The McNemar test used a 1:5 ratio for the cost for the imbalance of
data. The results are shown in Tables 5.10, 5.11, and 5.12. p-values representing
the statistical significance of the different performances in terms of AUC (< .05)
are shown in bold font in the referenced tables. There is no statistically significant
difference between DPFA and the HRV method. DPFA is significantly better than the
deep learning algorithm for 1-minute long prediction signals. DPFA is significantly
better than the DWT, CNN and CNN with LSTM method for most of the prediction
intervals. It is also worth noting that the performance of the DPFA algorithm with
raw ECG as input is also higher than the deep learning, DWT, CNN, and CNN with
LSTM methods.
5.3.2.4 Discussion
Many studies have focused on arrhythmia classification, but very few studies have
attempted to predict the onset of an SVT event. As compared to other methods such
as HRV, DWT, and deep learning, the method based on the DPFA algorithm has
achieved around 0.8 AUC for all prediction intervals.
Remarkably, the proposed novel DPFA algorithm utilizes minimal pre-processing
and does not require specific peak identification. The prediction results with raw ECG
signals are almost the same as the results with pre-processing. This method represents
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Figure 5.13: SVT predictions with DPFA, AUC for SVT prediction using the DPFA
method with and without pre-processing for various signal lengths and gap intervals.
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Figure 5.14: SVT prediction, AUC for SVT prediction for all models using various
signal lengths and gap intervals.
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Table 5.10: A comparison of AUC for SVT prediction with different gap intervals






































































































































































































a valuable alternative to traditional methods that require heavy pre-processing and
feature extraction.
We have compared the DPFA algorithms with five other algorithms. The HRV
with SVM method has good performance on SVT prediction when the dataset is
relatively small. The performance drops when applied to AHRE prediction. More-
over, the automated annotation algorithm for both methods are directly related to
the HRV features, which might have unknowingly affected the results. Several cases
in AHRE prediction were excluded as a result of difficulties in peak annotation for
the HRV with SVM method. The proposed DPFA method, on the other hand, does
not require a peak annotation algorithm. As a consequence, the DPFA algorithm is
more likely to perform better on other classification problems, where peak locations
are not among the primary features.
Neural network based algorithms such as deep learning, CNN, and CNN with
LSTM are similar to the DPFA algorithm in that no specific pre-processing is re-
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Table 5.11: A comparison of AUC for SVT prediction with different gap intervals




















































































































































































Table 5.12: A comparison of AUC for SVT prediction with different gap intervals

















































































































































quired. However, as shown in the experiments, they require a larger dataset for better
performance. The performances of these three algorithms are worse than DPFA and
HRV in SVT prediction due to the limited sample size.
There are several limitations of the study. The first limitation is the use of the
automated annotation algorithm. To validate the performance of the algorithm, the
positive cases were verified by a cardiologist, but not the negative cases. In a future
study, we aim to have the dataset annotated by clinicians, which is the gold standard
for annotations. The proposed DPFA model can be easily trained on other labeled
datasets. Secondly, extremely noisy sections of the ECG signals have been removed
from the beginning. These sections have been randomly checked by the clinicians
and most of them are not suitable for classifications. For the purpose of annotations
that rely on peak detection the signals were pre-processed and noisy sections were
excluded. In the future, using events manually annotated by clinicians, these noisy
sections can be included as an additional class for prediction instead of removing them.
Thirdly, the database used in this study is imbalanced, with many more negative cases
than arrhythmia cases. As a result, the costs and weights in the deep learning and
SVM models were adjusted accordingly to make the prediction more balanced. In the
future it is possible to employ additional data augmentation algorithms to increase the
positive cases, which may benefit both the deep learning and DPFA methods. Lastly,
the performance of the DPFA algorithm is still limited by the number of cases. Some
participants had substantially more cases than others, thus inter-patient ECG signal
variability may limit the performance of our algorithm as well as the other alternative
algorithms.
5.3.3 SVT Prediction with Data Collected from Portable Devices
DB4 and DB5 contains data with portable devices nad were used for SVT predic-
tion experiment. Details of DB4 and DB5 can be found in Section 4.4 and Section
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4.5. In DB4 and DB5, the SVT events were annotated using the FDA-cleared Beat-
Logic algorithm. Preventice BeatLogic platform, a comprehensive ECG annotation
platform that leverages deep learning for beat and rhythm detection/classification
Teplitzky et al. (2020).
Two sets of analyses were performed on this patient population:
• DB4 (participant number=55, SVT event number=27)
• DB4 and DB5 (participant number=129, SVT event number=27)
Details about the patient diagnosis are described in Table 4.6. The AUC for all
arrhythmia group in DB4 is around 0.79 - 0.87. The AUC for DB4 and DB5 combined
has is in the range of 0.78 - 0.92. The experiment results of these analysis are depicted
in Table 5.13 and Figure 5.15.
5.4 Ventricular Arrhythmia
Detection and prediction of ventricular arrhythmia events were performed on var-
ious databases. DB1 is constructed from publicly available databases and was used
VA detection experiment. Details of DB1 can be found in Section 4.2. For VA detec-
tion in DB1, the algorithm correctly identified 625/662 (0.94 sensitivity) VA episodes
and 600 /662 (0.91 specificity) non-VA episodes with an AUC of 0.97 and an F1-score
of 0.93 for the 2 seconds long signals. VT prediction experiment was performed with
DB2 using our own annotations. There are 77 reviewed episodes are obtained from
only 23 patients. The AUC for VT prediction is around 0.75. We did not perform
VT prediction in DB4/DB5 because we did not have any annotated events in these
2 databases.
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Figure 5.15: SVT prediction portable devices, AUC for SVT predictions.
87
Table 5.13: SVT prediction on data collected from portable devices, summary of
























0.5 0.5 0.820(0.003) 0.974(0.001) 0.890(0.002) 0.904(0.019)
1 0.5 0.836(0.007) 0.959(0.007) 0.855(0.002) 0.875(0.007)
1.5 0.5 0.847(0.005) 0.946(0.003) 0.857(0.002) 0.909(0.003)
2 0.5 0.848(0.009) 0.966(0.002) 0.855(0.001) 0.882(0.007)
2.5 0.5 0.791(0.010) 0.977(0.010) 0.836(0.003) 0.885(0.011)
3 0.5 0.786(0.039) 0.979(0.002) 0.821(0.006) 0.838(0.019)
3.5 0.5 0.832(0.007) 0.953(0.025) 0.780(0.014) 0.864(0.017)
4 0.5 0.860(0.003) 0.976(0.004) 0.787(0.008) 0.862(0.004)
4.5 0.5 0.806(0.018) 0.974(0.003) 0.790(0.007) 0.842(0.048)
0.5 1 0.863(0.000) 0.961(0.014) 0.926(0.009) 0.934(0.005)
1 1 0.865(0.003) 0.970(0.004) 0.917(0.008) 0.936(0.007)
1.5 1 0.866(0.005) 0.959(0.007) 0.910(0.007) 0.925(0.008)
2 1 0.833(0.011) 0.972(0.001) 0.898(0.006) 0.927(0.005)
2.5 1 0.839(0.005) 0.974(0.017) 0.879(0.014) 0.921(0.010)
3 1 0.853(0.004) 0.965(0.007) 0.868(0.011) 0.902(0.025)
3.5 1 0.852(0.007) 0.948(0.014) 0.849(0.007) 0.908(0.015)
4 1 0.827(0.002) 0.975(0.001) 0.830(0.005) 0.906(0.007)
0.5 2 0.870(0.003) 0.968(0.016) 0.894(0.012) 0.919(0.002)
1 2 0.858(0.002) 0.973(0.001) 0.883(0.010) 0.903(0.001)
1.5 2 0.858(0.002) 0.960(0.014) 0.869(0.010) 0.912(0.012)
2 2 0.859(0.003) 0.952(0.006) 0.865(0.007) 0.877(0.034)
2.5 2 0.856(0.002) 0.955(0.013) 0.846(0.009) 0.878(0.026)
3 2 0.850(0.005) 0.949(0.008) 0.837(0.009) 0.868(0.041)
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5.4.1 VA Detection on Benchmark Datasets
5.4.1.1 Data
Three publicly available data sets in DB1 with ventricular arrhythmia annotations
were used in the evaluation of the proposed method. As all three databases have been
examined by other algorithms, the proposed algorithm can be directly compared with
the performance of existing algorithms. The MIT-BIH Arrhythmia Database (mitdb)
contains 48 half-hour excerpts of two-channel ambulatory ECG recordings obtained
from 47 human subjectsGoldberger et al. (2000). The second database, the MIT-
BIH Malignant Ventricular Arrhythmia Database (vfdb), contains 22 half-hour ECG
recordings of subjects who experienced episodes of sustained VT, VFlutter, and VF
Goldberger et al. (2000). Lastly, the Creighton University Ventricular Tachycardia
Database (cudb) includes 35 8-minute long ECG recordings of human subjects who
experienced episodes of sustained VT, ventricular flutter, or VF Nolle et al. (1986).
The recordings from mitdb are sampled at 360 Hz, while those from vfdb and cudb
are sampled at 250 Hz.
5.4.1.2 Method
The vfdb and cudb databases are sampled at 250 Hz, while the mitdb database
is sampled at 360 Hz. Therefore, signals from mitdb were first re-sampled to 250
Hz. VA episodes including VT, ventricular flutter, and VF were extracted from the
re-sampled signals according to the ground-truth annotations. VA episodes from a
total of 28 patients were extracted. The signals from 22 ( 80%) patients were included
in the training data set and the remaining 6 patients were grouped into the testing
data set.
Signals were segmented into both 5-second and 2-second long episodes. A total
of 1409 5-second episodes were in the training data set and 261 episodes were in the
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testing data set. For the 2-second analysis, a total of 3667 episodes were in the training
data set and 662 episodes were in the testing dataset. Non-VA data was partitioned
in a similar way to ensure that the testing data set had a patient population disjoint
from the training data set.
Five-fold cross validation was performed at the patient level for parameter tuning
and to prevent over-fitting. The entire training data set was equally partitioned into 5
parts on the patient level. The first 4 parts were used as training data for generating
the Markov models and the last part was the validation data set. This process was
repeated five times. Average results for classification from all five experiments were
used to assess the performance. The sensitivity, specificity, F1-score, and AUC were
computed based on the training data set. The Markov model with the highest AUC
over the training data set was then applied to the testing data set to obtain the final
results.
5.4.1.3 Results
Performance was evaluated using 5-fold cross validation. Within the training data
set, the best result had an AUC of 0.92±0.05 and F1 score of 0.89±0.03 for 5-second
long episodes and AUC of 0.93 ± 0.03 and F1 score of 0.88 ± 0.04 for 2-second long
episodes.
The parameters in the model with highest AUC in the training data were then
applied to the testing data set. This testing set had a patient cohort separate from
the training data.
When evaluated over the testing data set, the proposed algorithm correctly identi-
fied 243 of 261 (0.93 sensitivity) VA episodes and 227 of 261 (0.87 specificity) non-VA
episodes for 5-second long signals. The AUC was 0.96 and the F1-score was 0.91
(Figure 5.16). For two-second long signals, the algorithm correctly identified 625 of
662 (0.94 sensitivity) VA episodes and 600 of 662 (0.91 specificity) non-VA episodes
90
Figure 5.16: Ventricular arrhythmia detection on publicly available benchmark
datasets, ROC curves for VA detection (5 seconds) and VA detection (2 seconds)
(Table 5.14) with an AUC of 0.97 and an F1-score of 0.93 (Figure 5.16).
Table 5.14: Ventricular arrhythmia detection on publicly available benchmark
datasets, confusion matrix for VA vs Non-VA with DPFA.
Annotation 5 seconds Annotation 2 Seconds
Prediction VA Non-VA Total VA Non-VA Total
VA 243 34 277 625 62 687
Non-VA 18 227 245 37 600 637
Total 261 261 552 662 662 1324
5.4.1.4 Discussion
The presented DPFA algorithm did not require any pre-processing or peak anno-
tation of the signals. It was able to detect 5-second long VA episodes with a high
AUC of 0.96 and F1-score of 0.91, and with an AUC of 0.97 and F1-score of 0.93
using 2-second long signals. Table 5.15 provides a performance comparison between
our algorithm and other algorithms. Note that the precise conditions and set-up of
these studies are not exactly the same.
There are multiple advantages of the proposed method over traditional feature
extraction with machine learning algorithm based approaches. First, the proposed
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Table 5.15: Ventricular arrhythmia detection on publicly available benchmark
datasets, results comparison to other methods.































































algorithm did not rely on the efficacy of any pre-processing algorithms to remove
noise and baseline wandering. Instead, the encoding algorithm uses filters and nor-
malizes the signals. Most pre-processing algorithms require prior knowledge of noisy
signals to build the best thresholds for filtering purpose. Our algorithm, by utilizing
a word distribution algorithm, is more adaptive to different types of noisy signals.
The second advantage was that the proposed algorithm did not require usage of an
ECG peak annotation algorithm. Thirdly, this algorithm did not need extensive prior
knowledge of the signals in order to build and extract features. Furthermore, even
though recent novel algorithms using CNNs do not require pre-processing or feature
extraction either, they still require longer training times and larger computational
resources. Finally, the proposed model was flexible, robust, and adaptable to other
types of arrhythmia like atrial fibrillation Li et al. (2018) and supraventricular tachy-
cardia. It has potential applications to portable devices that could perform detection
in real-time.
One limitation of the model was that it required a large number of good quality
annotated signals for training. However, for severe types of arrhythmia with low
prevalence such as VF, the number of annotated signals are limited.
Future work will utilize the proposed method to predict the onset of VA events
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several minutes in advance with real-time data from portable ECG devices.
5.4.2 VT Prediction on Hospital Bedside Dataset
5.4.2.1 Data
Waveforms in DB2 are used for VT predictions. After excluding recordings with
pacemakers, implantable cardioverter defibrillators (ICD) and ventricular assist de-
vices (VAD), there are 152 lead II ECG waveforms in the database from patients
diagnosed with VT.
5.4.2.2 Method
Each ECG recording could last up to several hours, we used 2 criteria to first filter
out the intervals that might contain VT episodes. The first criterion is the heart rate
should be above 100 bpm and the second criterion is average width corresponding to
half length of the peaks should be wider than 40 ms. The second criterion is defined
because VT episodes have wide QRS complex (> 120 ms), with half length of the
peaks > 40 ms, the width QRS complex will likely to be at least > 80 ms. We make
this criterion lower than the 120 ms, to make sure that we capture all the possible
VT episodes for manual review. Details about annotation algorithms in 3.3.1.
The last step of VT annotation requires manual review of the episodes which
satisfied the two criteria. There is a total of 77 VT episodes after review, 59 of them
were included in the training dataset and the remaining 18 episodes were included
in the testing dataset. Five-fold cross validation was performed on training data on
participant level for parameter tuning. The parameters with highest sensitivity was
then applied on the testing set.
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AUC F1 Sensitivity Specificity Acc
0.5 2 0.78 0.55 0.67 0.84 0.84
1 2 0.77 0.50 0.56 0.84 0.79
1.5 2 0.76 0.50 0.50 0.85 0.72
2 2 0.75 0.52 0.33 0.86 0.76
2.5 2 0.75 0.48 0.44 0.85 0.72
3 2 0.76 0.52 0.56 0.85 0.81
5.4.2.3 Results and Discussion
The AUC for VT prediction is around 0.75, results on DB2 are shown in Table
5.16. The VT prediction results which are not as good as other types of arrhythmias
like AFib or SVT. The major limitation of VT prediction is the limited number of data
compares to other arrhythmia types. There are only 77 reviewed episodes obtained
from 23 patients.
5.5 Bradycardia
5.5.1 Bradycardia Detection on Benchmark Datasets
Comparing to other types of arrhythmias, bradycardia does not cause as severe
symptoms and have less research interests. Thus there are limited publicly available
databases built for bradycardia events. Bradycardia events in DB1 is limited and
experiments were not performed due to the small sample size.
5.5.2 Bradycardia Prediction on Hospital Bedside Dataset
Bradycardia in adults may cause complications in many kinds of chronic heart
disease. On the other hand, bradycardia is also linked to various kinds of emergencies
in situations such as when driving an automobile. It is thus crucial to monitor and
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make automated urgent detection, preferably even to predict these bradycardia events
in such situations. The aim of the study is to predict the onset of bradycardia
events in patients with congestive heart failure (CHF), with the purpose to inform
the development of an in-vehicle cardiac monitoring system.
Arrhythmia is a condition of improper beating of the heart, whether too fast or
too slow or irregularly, which occurs when the electrical impulses that coordinate the
heart beats are not working properly. Among various types of arrhythmia, tachycardia
refers to a fast heart beat generally with a resting heart rate greater than 100 beats-
per-minute (BPM), whereas bradycardia, on the other hand, refers to a slow heart
beat commonly defined as having a heart rate of less than 60 BPM Kusumoto et al.
(2019). Despite the general definition, a slow heart rate does not always indicate an
underlying disease, since there is considerable variation in the resting heart rate among
the healthy, asymptomatic population Mangrum and DiMarco (2000) such as the
example of people with a family history of slow heart beats, or athletes and physically
active individuals. However, bradycardia can cause inadequate blood flow to tissues
and organs leading to symptoms such as fatigue, dizziness or heart failure Mangrum
and DiMarco (2000). In more severe cases, certain symptomatic bradycardia could
be caused by a serious underlying medical condition known as congestive heart failure
(CHF), which is manifested by signs and symptoms of impaired cardiac ventricular
performance. The ten-year mortality rate for CHF is 54.4% for men and 23.8% for
women for the population with 25-74 years of age Schocken et al. (1992). Damage to
the heart from CHF and other heart problems may affect the heart’s electrical system,
making the heart pump less efficiently and effectively and causing bradycardia. Upto
5 million patients experience CHF in United States and sudden cardiac death remains
a significant problem in this population. Although most sudden deaths in CHF can
be attributed to ventricular arrhythmia, bradycardia is another prominent cause and
accounts for 42% of sudden deaths in hospital Sanders et al. (2004). In order to
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prevent the negative effects of bradycardia for patients with life threatening cardiac
disease such as CHF, it is crucial to not only make early detection, but also to predict
the onset of bradycardia events.
Many studies on bradycardia prediction have focused on the detection or pre-
diction of severe bradycardia including apnea bradycardia in premature newborns.
Various techniques have employed statistical methods and machine learning methods
such as nonparametric methods Das et al. (2019) and point process modeling Gee
et al. (2016) to extract statistical features, deep sequential auto-encoders and on-
line clustering Hosseini and Sarrafzadeh (2019), Kalman filter Ghahjaverestan et al.
(2015b), principal components analysis (PCA) and hierarchical ascending classifica-
tion (HAC) for clustering and classification Pravisani et al. (2003), hidden Markov
model Ghahjaverestan et al. (2015a, 2021); Altuve et al. (2011); Sadoughi et al. (2021),
system identification-based approach Bakshi et al. (2020) and fusion of different algo-
rithms Cruz et al. (2006). However, when it comes to bradycardia prediction in adults
there is limited research efforts, especially in patients with severe cardiac disease such
as heart failure. Therefore, this study aims to achieve two goals: from a methodology
perspective, to apply a new approach based on DPFA into the study of bradycardia
prediction; from a medical perspective, to fill the gap in adult bradycardia predic-
tion by developing such an algorithm for patients with underlying cardiac diseases.
For those who are not familiar with the definition, a DPFA is an automaton with
a finite number of states on a pre-determined finite alphabet consisting of possible
deterministic transitions, such that at each time the transition from one state to the
next is determined by a probability distribution on the alphabet depending only on
the current state. For further details please refer to Li et al. (2019, 2021), algorithm
related to bradycardia prediction is listed in Section 3.3.1.
In this part of the study, a DPFA based algorithm is proposed to monitor and
predict bradycardia events, with the goal to create a real-time, prospective system
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that can help clinical practice and prevent negative outcome due to sudden drop in
heart rates in CHF patients.
5.5.2.1 Data
The analysis is based on lead II electrocardiogram (ECG) recordings. The ECG
signals were extracted from a retrospective database from Michigan Medicine cardiac
patients with bradycardia diagnosis. Recordings from patients with pacemakers, im-
plantable cardioverter defibrillators (ICD), or ventricular assist devices (VAD) were
further excluded. The recordings were sampled at 240 Hz.
There was a total of 2156 lead II ECG recordings from 1251 bradycardia patients.
Among these 2156 recordings, 287 were from 173 CHF patients. After extracting
bradycardia events with annotation criteria, a total of 95 bradycardia intervals from
47 patients. Among these events, a total of 21 bradycardia annotated events from 11
patients did not take beta-blockers. The patients without beta-blockers were sepa-
rated out to test the severe bradycardia cases that were not related to beta-blockers.
Beta-blockers are commonly used in treatment for heart failure and arrhythmia. They
are thought to work by blocking the deleterious effects of adrenergic receptor stimu-
lation.This results in a slowing of the heart rate and reduces the force at which blood
is pumped around your body. Studies suggest that treatment to reduce resting heart
rate in patients with heart failure to < 65 bpm is associated with a better prognosis.
However, risk must increase with very low heart rates Cullington et al. (2012). Lead II
ECG was used because it shows the p-wave and is most commonly used to record the
rhythm strip. As a result, analyses based on hand-crafted clinical features mostly use
lead II ECG signals. Table 5.17 summarizes demographics of the 47 patients included
in the study and the sub-group with 11 patients with no beta-blockers. Among the
47 patients, 57% of them were males with an average of age of 64.7. All of them
were cardiac arrhythmia patients with congestive heart failure. Among them 30%
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Age <= 50 11 (23%) 3 (27%)
51-60 7 (15%) 1 (9%)
61-70 10 (21%) 3 (27%)
71-80 13 (28%) 3 (27%)
>80 6 (13%) 1 (9%)
Gender Female 20 (43%) 3 (27%)
Male 27 (57%) 8 (73%)
Cardiac Arrhythmia Yes 47 (100%) 11 (100%)
No 0 (0%) 0 (0%)
Chronic Pulmonary Disease Yes 14 (30%) 4 (36%)
No 33 (70%) 7 (64%)
Congestive Heart Failure Yes 47 (100%) 11 (100%)
No 0 (0%) 0 (0%)
Hypertension Complicated Yes 15 (32%) 2 (18%)
No 32 (68%) 9 (82%)
Hypertension Uncomplicated Yes 35 (74%) 8 (73%)
No 12 (26%) 3 (27%)
Diabetes Complicated Yes 11 (23%) 2 (18%)
No 36 (77%) 9 (82%)
Diabetes Uncomplicated Yes 17 (36%) 4 (36%)
No 30 (64%) 7 (64%)
Pulmonary Circulation Disorders Yes 18 (38%) 5 (45%)
No 29 (62%) 6 (55%)
had chronic pulmonary disease, 32% had complicated hypertension and 74% of them
had pulmonary circulation disorders.Among the 11 patients, 73% of them were males
with an average of age of 63.5. Among them 36% had chronic pulmonary disease, 18%
had complicated hypertension and 45% of them had pulmonary circulation disorders.
5.5.2.2 Method
In order to extract bradycardia events that have more clinical importance, sev-
eral criteria were employed in terms of heart rate, medical diagnosis and medication.
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Details about the bradycardia annotation algorithms are described in Section 3.3.4.
Pre-processing, noise removal and pre-event extractions are described in Section 3.4.1,
3.4.2.2 and 3.4.3. Details of the DPFA algorithm is described in Section 3.2. Sym-
bolization of the DPFA algorithm is described in Section 3.2.2, parameters are tuned
with training and validation data and the optimal parameters are listed in 5.2.







For prediction of bradycardia in patients with or without beta blockers, five-fold
cross-validation was used for model training, testing and validation. A total of 80
prediction intervals from 38 patients were used in training with the remaining 18
intervals from 9 patients were held out for testing. Within the training data set, 5-
fold cross validation was performed for parameter tuning. Training, cross validation,
and testing sets/folds were partitioned on the participant level, meaning that signals
from the same participant were only included in one set/fold so as to prevent data
leakage. The training-testing process was repeated for 10 times to avoid biased results
due to randomness in training and testing data partition (Figure 5.17).
For prediction of bradycardia in patients without beta blockers, leave-five-out
cross-validation was used for training and testing the model performance. The choice
of leave-p-out instead of k-fold cross-validation was because of the limited sample
size. There was a total of 11 bradycardia participants without beta blockers. For
each iteration, 5 participants were chosen for the testing set and the remaining 6
participants were used to train the model (Figure 5.18). The choice of p = 5 ensures
enough bradycardia cases in both the training and the testing datasets. For p smaller
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Figure 5.17: Bradycardia prediction on hospital bedside dataset (DB2), training
scheme plot for five-fold cross validation.
Figure 5.18: Bradycardia prediction on hospital bedside dataset (DB2), training
scheme plot for leave-five-out cross-validation.
than 5, the results of the experiments were influenced by how the data was separated,
causing a larger variance. The same issues arose for p larger than 6 by symmetry.
Similar to five-fold cross-validation, the dataset was also split on the participant level
to prevent data leakage. A total of 11C5 = 426 iterations were performed to evaluate
the models and the final result was the average of all the iterations.
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5.5.2.3 Results
Different combinations of signal intervals (i.e., tprediction = 0.5, 1.0, 2.0 minutes)
and gap intervals (i.e., tgap = 0.5, 1.0, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5 minutes) were used for
prediction. These prediction intervals were tested using the DPFA algorithm.
Figure 5.19 shows a summary of the performance for the overall group includ-
ing patients with beta-blockers. The overall average AUC is 0.67 with a standard
deviation of 0.05. The average AUC is 0.67 ± 0.05 for tprediction = 0.5, 0.68 ± 0.05
for tprediction = 1.0 and 0.68 ± 0.05 for tprediction = 2.0. The AUC is around 0.7 for
all prediction intervals. For the bradycardia-positive DPFA, the algorithm generated
an average of 607 × 3 transition states for the models using 0.5-minute long signals,
267×3 transitions states for the 1.0-minute long signal models, and 3867×3 transition
states for the 2.0-minute long signal models. For the bradycardia-negative DPFA, the
algorithm generated an average of 1949×3 transition states for the models using 0.5-
minute long signals, 2483× 3 transitions states for the 1.0-minute long signal models,
and 3037× 3 transition states for the 2.0-minute long signal models.
Figure 5.20 shows a summary of the performance for the group without beta-
blockers. The overall average AUC is 0.72 with a standard deviation of 0.13. The
average AUC is 0.71 ± 0.13 for tprediction = 0.5, 0.72 ± 0.14 for tprediction = 1.0 and
0.73 ± 0.12 for tprediction = 2.0. The AUC is around 0.7 for all prediction intervals.
For the bradycardia-positive DPFA, the algorithm generated an average of 19 × 3
transition states for the models using 0.5-minute long signals, 30×3 transitions states
for the 1.0-minute long signal models, and 61× 3 transition states for the 2.0-minute
long signal models. For the bradycardia-negative DPFA, the algorithm generated an
average of 58×3 transition states for the models using 0.5-minute long signals, 108×3
transitions states for the 1.0-minute long signal models, and 471× 3 transition states
for the 2.0-minute long signal models.
There are two major groups of arrhythmia detection algorithm based on ECG
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Figure 5.19: Bradycardia prediction on hospital bedside dataset (DB2), AUC for
various signal lengths and gap intervals.
Figure 5.20: Bradycardia prediction on hospital bedside dataset (DB2), AUC for
various signal lengths and gap intervals, without beta-blockers.
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Table 5.18: Bradycardia prediction on hospital bedside dataset(DB2), result for














0.5 0.5 0.732(0.12) 0.655(0.23) 0.637(0.20)
1 0.5 0.728(0.18) 0.565(0.25) 0.719(0.21)
1.5 0.5 0.737(0.11) 0.589(0.24) 0.696(0.21)
2 0.5 0.726(0.12) 0.765(0.26) 0.527(0.32)
2.5 0.5 0.717(0.14) 0.703(0.27) 0.596(0.23)
3 0.5 0.733(0.11) 0.577(0.25) 0.701(0.21)
3.5 0.5 0.744(0.14) 0.838(0.17) 0.510(0.28)
4 0.5 0.743(0.12) 0.811(0.20) 0.510(0.31)
4.5 0.5 0.743(0.12) 0.448(0.24) 0.778(0.17)
0.5 1 0.715(0.13) 0.835(0.18) 0.506(0.29)
1 1 0.731(0.13) 0.770(0.25) 0.544(0.31)
1.5 1 0.715(0.12) 0.561(0.26) 0.694(0.22)
2 1 0.707(0.12) 0.721(0.27) 0.571(0.25)
2.5 1 0.730(0.14) 0.767(0.24) 0.537(0.31)
3 1 0.743(0.12) 0.448(0.24) 0.778(0.17)
3.5 1 0.713(0.13) 0.751(0.28) 0.568(0.26)
4 1 0.699(0.13) 0.768(0.27) 0.512(0.33)
0.5 2 0.722(0.12) 0.538(0.24) 0.704(0.21)
1 2 0.674(0.14) 0.668(0.30) 0.561(0.28)
1.5 2 0.704(0.13) 0.752(0.26) 0.522(0.32)
2 2 0.700(0.13) 0.666(0.30) 0.621(0.26)
2.5 2 0.719(0.12) 0.736(0.28) 0.598(0.28)
3 2 0.702(0.13) 0.702(0.28) 0.595(0.27)
signals. The first group requires the extraction of hand-crafted features from time or
frequency domain, followed by a machine learning classifier. The second group does
not rely on hand-crafted features Faust et al. (2020), but instead uses deep learning
methods such as convolutional neural networks (CNN) or long short-term memory
(LSTM) recurrent neural networks (RNN) Acharya et al. (2017a); Rajpurkar et al.
(2017); Acharya et al. (2017b).
In order to evaluate the performance of the DPFA algorithm relative to the other
methods, the prediction experiments were performed with the same leave-five-out
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training-testing scheme using the following algorithms:
1. Heart rate variability (HRV) features with random forest (RF). A total of 22 fea-
tures were extracted from time-domain, frequency-domain and non-linear mea-
surements. Time-domain features include: HR, RR, SDNN, SDHR, RMSSD,
NN50, pNN50, SDSD, HRV TRI, and TINN. Frequency-domain features in-
clude: LF peak, HF peak, LF power, HF power, LFHF ratio, and VLF. Non-
linear measurements include: SD1, SD2, Lorenz OC, Lorenz OC ratio, ApEN,
and SampEn. See Table 5.19 for definition and full names of the variables Shaf-
fer and Ginsberg (2017); Sarkar et al. (2008); Hnatkova et al. (1995); Grant
et al. (2013).
RF was used with grid search on number of trees, number of features at every
split, maximum number of levels in trees, minimum number of samples required
to split a node and minimum number of samples required at each leaf node.
2. 1D-CNN model: 1D-CNN model with 2 layers with ReLU activation followed
by a dropout layer for regularization and a pooling layer. The learned features
were then flattened and passed to a fully connected layer.
3. CNN-based ResNet: ResNets use a skipping mechanism to connect non-adjacent
layers, thus making the features more robust to perturbations and improving
the accuracy of deeper networks Andreotti et al. (2017). A 34 layers ResNet was
applied to classify 30-seconds long single lead ECGs segments into 14 different
cardiac disease classes with raw ECG data Rajpurkar et al. (2017). A ResNet
with three residual blocks followed by a global average pooling layer and a
softmax layer was used in this study for comparison.
For the CNN-based models, architectures with fewer layers were chosen because
of the limited sample size.
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Table 5.19: Bradycardia prediction on hospital bedside dataset(DB2), table of fea-
tures used in HRV with RF approach.
Parameter Description
HR Mean heart rates
RR Mean of time elapsed between two successive R waves of the QRS signal
SDNN Standard deviation of NN intervals
SDHR Standard deviation of heart rates
RMSSD Root mean square of successive RR intervals
NN50
Number of adjacent NN intervals that differ from each other
by more than 50 ms requires a 2 min epoch
pNN50 Percentage of successive RR intervals that differ by more than 50 ms
SDSD Standard deviation of successive RR interval differences
HRV TRI Integral of the density of the RR interval histogram divided by its height
TINN Baseline width of the RR interval histogram
LF Peak Peak frequency of the low-frequency band (0.04-0.15 Hz)
HF Peak Peak frequency of the high-frequency band (0.15-0.4 Hz)
LF Power Absolute power of the low-frequency band (0.04-0.15 Hz)
HF Power Peak frequency of the high-frequency band (0.15-0.4 Hz)
LFHF ratio Ratio of LF-to-HF power
VLF Absolute power of the very-low-frequency band (0.0033-0.04 Hz)
SD1 Poincaré plot standard deviation perpendicular the line of identity
SD2 Poincaré plot standard deviation along the line of identity
Lorenz OC Number of points within the radius of normal sinus rhythm mask (80 ms)
Lorenz OC ratio
Ratio between number of points within the radius NSRmask to the




The dataset in this study is imbalanced; in the total group there are 98 bradycardia
intervals with around 1000 non-bradycardia intervals, in the group without beta-
blockers there are 21 bradycardia cases with 371 non-bradycardia cases. A direct
application of deep learning methods might be ineffective since these typically require
much larger data sets and a more balanced class. In order to balance the two classes,
each comparison method was then applied together with the synthetic minority over-
sampling technique (SMOTE). SMOTE is a popular oversampling method proposed
by Chawla in 2002, it can produce synthetic minority samples instead of duplicating
samples Chawla et al. (2002). In the HRV with RF approach, the SMOTE method
was applied after the HRV feature extraction step, in order to amplify the features
extracted from the bradycardia group so as the achieve an equal number with the
non-bradycardia group. In the CNN based method, SMOTE was applied to the raw
training ECG to balance the number of the two classes.
In the total group including beta-blocker patients, the HRV with RF algorithm has
an average AUC of 0.54± 0.03, sensitivity of 0.12± 0.07 and specificity of 0.97± 0.02
over all prediction intervals. There was a slight improvement after data augmentation
with SMOTE, the algorithm achieved AUC of 0.57 ± 0.04, sensitivity of 0.24 ± 0.20
and specificity of 0.89 ± 0.04. Similarly in the group without beta-blocker patients
using HRV with RF, data augmentation with SMOTE also resulted in with an average
AUC of 0.55 ± 0.08 , sensitivity of 0.23 ± 0.20 and specificity of 0.87 ± 0.13. over
all the prediction intervals, a slight improvement over the otherwise AUC of 0.5.
However, there was not much improvement for CNN based methods, the AUC for
the prediction intervals were still around 0.5. The algorithms failed to classify the
minority class. This might due to the inherent requirement for larger datasets of deep
learning algorithms in order to achieve better classification results.
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5.5.2.4 Discussion
Despite active research in bradycardia prediction for premature infants, there have
been only a limited number of studies in the adult population with CHF. In this study,
lead II ECG signals were used to predict bradycardia events up to 5 minutes prior
to the onset of the event. The proposed algorithm uses DPFA models to predict
bradycardia events. The processed ECG is transformed to a probabilistic string of
symbols representing broad morphology types for model generation. The generated
models are then applied to the testing set for the prediction. An AUC of around 0.7
was achieved for all prediction intervals despite a relatively small sample size. To
investigate impact of beta-blockers, analysis performed on patients without taking
beta-blockers. With DPFA algorithm, there is a slightly increase in the prediction
performance, however the variance has increased as well.
The proposed method does not rely on the extraction of hand-crafted features
which requires extensive clinical knowledge. With a well-trained model, the algorithm
has the ability to predict the events in a real-time prospective manner. This will allow
time for medical attention for bradycardia events in patients with CHF. This will be a
significant step toward the development of an in-vehicle arrhythmia prediction system.
One of limitations of the study is the small sample size. Although the entire
bradycardia dataset consisted of 1251 bradycardia patients to start with, there were
only 47 patients that met all the criteria for inclusion and for the beta-blocker excluded
group there were only 11 patients. The strict criteria were imposed in order to focus
on patients who were not only with bradycardia episodes but also had CHF, since it
is also possible for healthy individuals such as athletes to have low heart rate but with
no significant health concerns. Patients taking beta blockers were also excluded due
to the medication effects on ECG signals. Although the goal was to include patients
that would benefit most from a clinical alert system, this approach also led to a
low number of patients thus limiting the ECG patterns that can be used for model
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training. The leave-five-out training method was applied for algorithm evaluation,
but a larger patient cohort could further help with algorithm training. The limited
sample size also made it difficult to compare the performance the DFPA algorithm
with any state-of-the-art deep learning algorithms, since the latter typically require
much larger training dataset. In future studies, more patients with ECG signals that
can be used for model training and evaluation will be enrolled.
5.6 Rapid Ventricular Rates with Low Activity
RVR are an important consequence of AFib January et al. (2014). A fast and ir-
regular heart rate decreases time spent in diastole which impairs myocardial perfusion,
ventricular diastolic filling, and cardiac output that in turn leads to greater symptom
burden and reduced left ventricular systolic function Skinner Jr et al. (1964); Kochi-
adakis et al. (2002). However, there are many reasons for RVR during episodes of
AF. In addition to inappropriate tachycardia due to the underlying disease, patients’
heart rates may rise in a normal compensatory response to keep up with physiological
demands during exercise or activities of daily living.
There is a need to not only detect and predict periods of AF with rapid ventric-
ular rates but also distinguish periods of inappropriate tachycardia with AF from
those associated with activity. Accelerometers are widely used in wearable sensors
and provide important data that can be used to estimate patients’ activity and move-
ment within their natural setting Godfrey et al. (2008). They can provide important
insights that are not available through investigating ECG alone. Therefore using raw
accelerometry data in combination with ECG has the potential to identify and predict
inappropriate tachycardia with AF. Accurate prediction of these episodes will allow
just-in-time interventions for patients with AF.
Traditional algorithms have focused on the detection of AF episodes and are able
to achieve this with high degree of accuracy Teplitzky et al. (2020). However, predic-
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tion algorithms have not been able to achieve sufficient lag time to allow for medical
or surgical interventions. There are several clinical scenarios where identifying rapid
AF at low levels of activity can be of clinical value, including ensuring appropriate
rate control for patients with AF, triggers for on-demand rhythm control approaches
to improve patient care and facilitate monitoring system for AF that could be treated
medically.
The aim of this part of study is to predict the onset of AF with RVR episodes
associated with low activity using pre-event ECG signals. The proposed approach
involves a DPFA-based algorithm that can predict episodes of AF with RVR that are
associated with low levels of activity.
5.6.1 Data
A total of 45 patients with history of AF who presented to University of Michigan
are recruited in the study. All patients wore an event recorder (Preventice solutions
Inc) for up to three weeks. IRB approved the protocol and written informed consent
was obtained. The ECG and accelerometer data were recorded continuously for up to
3 weeks. Thirteen patients are excluded because the length of the ECG is less than 5
minutes or there are no annotated AF events, 1 additional patient is excluded since no
accelerometer data. Thirteen patients with AF episodes of duration less 30 seconds
or less than 5 episodes of AF were further excluded. Finally a total of 18 patients are
included in the prediction analysis. A flow chart of the patient inclusion/exclusion
criteria is demonstrated in Figure 5.21. The characteristics of patients are summarized
in Table 5.20.
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Figure 5.21: RVR with low activity prediction, figure of patient flow.
5.6.2 Method
5.6.2.1 Accelerometer data
The raw accelerometer data are collected along three orthogonal axes in the device-
specific frame of reference. The continuous accelerometer data are collected using
a wireless monitoring device that adheres to patient’s chest (Preventice Solutions,
Inc) and sampled at 10 Hz. The accelerometer data were up-sampled to 256 Hz to
match the ECG sampling rate. For the analysis, the accelerometer magnitude am(t)
consisting of the vector magnitude of the accelerometer data at each time point is
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Participants in Prediction Analysis
(n=18)
Female 14 (31.82%) 5 (27.78%)
Age 66.36 (11.67%) 69.13 (7.31%)
BMI 31.30 (6.08%) 30.93 (5.66%)
Hypertension 26 (59.09%) 11 (61.11%)
History of Stroke 0 (0.00%) 0 (0.00%)
Diabetes 12 (27.27%) 5 (27.78%)
Coronary artery disease 11 (25.00%) 5 (27.78%)
Peripheral vascular disease 2 (4.54%) 2 (11.11%)
Beta Blockers 31 (70.45%) 13 (72.22%)
Calcium channel blockers 14 (31.82%) 4 (22.22%)
Antiarrhythmic drugs 9 (20.45%) 2 (11.11%)
used in analysis together with the synchronized ECG signal.
am(t) =
√
x(t)2 + y(t)2 + z(t)2
= accelerometer magnitude at the time point t.
(5.3)
The data is aggregated using MAD which computes the deviation of am(t) from
its mean over the corresponding epoch, averaged over the length of the annotated AF









am(ti) = accelerometer magnitude at the ith time point
am = mean accelerometer magnitude within the time period of interest
n = length of the time period
The MAD ≤ 0.75 quantile relative to the measurements from the entire group id des-
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ignated as low activity and MAD > 0.75 quantile as high activity in order to account
for inter-individual differences in activity levels within the study group. Threshold of
0.75 quantile for distinguishing activity levels is an arbitrary choice since there is no
well-established guideline for low vs. high activity level.
5.6.2.2 ECG data
ECG is acquired using a single lead event recorder (Preventice Solutions, Inc)
and sampled at 256 Hz. ECG data were collected with the same biopatch as the
accelerometer. Continuous single channel ECG signals were collected while wearing
the device. Arrhythmia classification was performed using the BeatLogic platform
that is cleared to identify AF episodes Teplitzky et al. (2020). Our clinician has
also reviewed 150 randomly selected AF events annotated by Beatlogic for further
validation, out of which 139 (93%) were confirmed to be AF events. A total of 961
AF events were annotated by the algorithm. Most of the participants had less than 50
episodes of AF events throughout the 3 weeks with several participants with higher
number of AF events. Figure 5.22 shows burden of AF for all participant and those
included in the prediction algorithm analysis.
In terms of HR, RVR episodes are defined as having HR > 110 BPM, and non-
RVR episodes with HR ≤ 110 BPM. Pre-processing, noise removal, and prediction
interval extraction were performed on the synchronized recordings of ECG and ac-
celerometer magnitude signals.
In the signal pre-processing step, a second-order Butterworth band-pass filter
was applied with cutoff frequencies of 0.5 and 40 Hz to the raw ECG signal for
noise removal. In the next step, a double median filter with orders equal to 0.2 and
0.6 times the sampling frequency was applied to remove baseline wandering. Peak-
detection algorithm was then applied to capture the R-peaks in the ECG signals.
Noise section of the signals was detected with annotations from BeatLogic platform.
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Events that occurred too close to previous events were excluded to avoid overlap
of prediction intervals with arrhythmia events. Events that occurred within 8 minutes
of a noisy signal were also excluded to ensure that the prediction interval is outside
the noisy signal range. We used the ECG signal to predict episodes of AF with RVR
and low activity level vs. all other AF episodes.
The gap interval tgap represents the interval in minutes before the event that is
used for prediction. The signal interval tsignal represents the length of the prediction
signals. For example, prediction intervals with tgap = 1 min, tsignal = 2 min are the
signals that span from 3 to 1 minutes before the annotated events. Figure 5.23 shows
an example of an annotated AF episode and prediction intervals.
5.6.2.3 DPFA Model
In this part study, we improved our algorithm and tested its ability to work
with different types of synchronized physiological signals (i.e synchronized ECG with
accelerometer magnitude signals) for arrhythmia events predictions. We used the
DPFA algorithm for predicting AF episodes with RVR and low activity level vs. other
AF episodes using ECG and accelerometer magnitude signals prior to the event.
Each DPFA is generated in two steps (see 3.2 for details of the algorithm):
First in the symbolization module, one begins with the training dataset which
consists of annotated ECG and accelerometer magnitude signals. From these, the
algorithm extracts windows that are indicative of imminent events and others that
are not. The positive (i.e., AF with RVR with low activity) and negative (i.e., all the
other regions) ECG and accelerometer magnitude signals are respectively combined
and transformed into probabilistic strings. Here the probabilistic strings consist of an
alphabet of nine symbols Σ = {α1β1, α2β1, α3β1, α1β2, α2β2, α3β2, α1β3, α2β3, α3β3}
where αi correspond to different activity levels and βj correspond to different ECG
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morphology types within each window, and the probabilities
p(αiβj) = p(αi)p(βj) (5.5)
are computed by assigning probabilities to αi and βj independently. The individual
probabilities p(αi) and p(βj) are obtained from the signal values xt over discrete time








p3 = 1− p1 − p2,
(5.6)
where the soft-thresholding functions are chosen to be piecewise linear functions
ψ1, ψ2 : [0, 1]→ [0, 1] of the form
ψj(x) =

1 if x > bj
x−aj
bj−aj if aj ≤ x ≤ bj
0 if x < aj.
(5.7)












for ECG βj. (5.8)
based on a grid search while running the inner loops of the nested cross validation.
Then the DPFA generation module constructs the positive (AF with RVR and low
activity) DPFA M+ and the negative (all other AF episodes) DPFA M− respectively
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from the positive and negative probabilistic strings, by first constructing the frequency
prefix trees T+ and T−, followed by the largest suffix merging algorithm T+ → M+
and T− →M−. The frequency prefix trees are tree-like automata T = 〈Q0,Σ, ε,Freq〉
with initial state ε whose state space Q0 consists of strings in the alphabet Σ with
non-zero frequency, and transition function given by concatenation of strings. The
largest suffix merging algorithm selects those states q ∈ Q0 of the frequency prefix
tree T with sufficiently high frequency to be in the state space M , and then defines
the transition state T (q, αiβj) to be the largest suffix of qαiβj that is itself contained
in the state space of M . See 3.2 for further details.
The classification scheme contains a training phase and a testing phase. In the
training phase, the algorithm learns the DPFA M+ and M− for the positive and
negative classes respectively. Then in the testing phase, we classify a given synchro-
nized ECG-accelerometer magnitude signal from the test dataset by comparing the
goodness-of-fit with the DPFA M+ and M− to predict episodes of AF with RVR with
low activity Figure 5.24.
5.6.3 Data Partition
A total of 961 episodes of AF events were annotated for the analysis. We used 5
fold nested cross validation for parameter tuning. Figure 5.25 shows how data was
partitioned in the analysis. The 961 episodes were split into 5 folds, 4 folds were used
for training and the remaining fold was used for testing. Within the inner loop, the
training data had a total of 4 folds, 3 folds were used for parameter tuning and the
remaining fold for validations. In the outer loop, the DPFA models were generated
using all 4 folds of the training data with hyper-parameters tuned during the inner
loop. Predictions were performed on the testing data in each split and then averaged.
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5.6.4 Results
During the study period, we have recruited 45 patients with AF, of whom 31 had
both ECG and accelerometer data. We excluded patients with AF episode of duration
less 30 seconds and those with less than 5 episodes of AF. There was a total of 292
episodes of AF with RVR compared to 669 episodes of AF with controlled heart
rate. There were 116 episodes in > 75 percentile activity level in the RVR group
and 124 episodes in the non-RVR group based on MAD relative to total group. The
distribution of high activity based on heart rates above 110 BPM are summarized in
Table 5.21. The 45 participants in the study had a median of 22 days of total wear
time (range 2–31 days). The median overall AF burden was 38.4% (inter-quantile
range (IQR) 4.9%-86.0%).
Among the 961 annotated AF events, 292 of them met the criterion for RVR
episode, among which 176 episodes had low activity level and the remaining 116
episodes had high activity level based on MAD relative to the entire group activity
level. For the rest of the annotated AF events, 669 of them were non-RVR episodes,
among which 545 episodes had low activity and the remaining 124 episodes had
high activity level. Table 5.21 summarizes the number of annotated AF episodes by
activity and HR levels.
A total of 18 patients are included in the final DPFA model. They had a median
of 22 days of total wear time (range 6–31 days). The median overall AF burden for
the 18 patients was 19.7% (IQR 10.5%-62.3%). Two participants had an AF burden
> 90% over the duration of the study. The mean heart rate was 99.0 ± 19.4 BPM.
The burden of AF for study participants is summarized in Figure 5.22.
Different combinations of signal intervals (i.e., tsignal = 0.5, 1.0, 2.0 min and gap
intervals (i.e., tgap = 0.5, 1.0, 2.0, 2.5, 3.5, 4.0, 4.5 min) up to 5 minutes before the AF
events were used for prediction. For a given model based on various gap intervals,
the threshold can be adjusted to optimize different parameters, i.e., a more sensitive
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Table 5.21: AF episodes by activity level and HR level.
Low Activity High Activity Total
RVR 176 116 292
Non-RVR 545 124 669
Total 721 240 961
model vs a more specific model. In Table 5.22, we report the threshold, sensitivity,
specificity, precision, and other relevant data based on each gap interval.
5.6.4.1 Results
We limited the events to those that lasted for at least 30 seconds to investigate the
effects of AF duration on predicting episodes of AF with RVR with low activity. As
the time to the event increases, the mean prediction performance gradually declines
while the variance increases. Using the MAD threshold relative to the whole group,
the average AUC for 0.5 minute-long prediction intervals is 0.71 ± 0.04, 1 minute-
long is 0.75± 0.03 and 2 minute-long is 0.77± 0.03 (Figure 5.26).The 2 minute-long
prediction intervals also showed the highest AUC around 0.75 with smallest standard
deviations. Prediction results for various gap intervals and prediction intervals are
shown in Table 5.22.
5.6.4.2 DPFA model interpretation
In addition to the superior performance, another major advantage of our approach
is the interpretability of the underlying DPFA models. Indeed the DPFA models could
be understood by first calculating the relative frequencies of the states, and then iden-
tifying the most prevalent rhythm patterns represented by the states within the DPFA
model constructed from each class. This could be achieved via standard techniques
by first extracting the normalized leading eigenvector of the transition matrix of the
DPFA model, and then taking the average of the relative frequencies across the five
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0.5 0.5 0.735(0.026) 0.552(0.049) 0.808(0.104) 0.806(0.027)
1 0.5 0.700(0.050) 0.546(0.075) 0.797(0.085) 0.811(0.035)
1.5 0.5 0.725(0.041) 0.545(0.098) 0.804(0.078) 0.810(0.024)
2 0.5 0.706(0.064) 0.527(0.111) 0.810(0.084) 0.799(0.027)
2.5 0.5 0.729(0.048) 0.521(0.103) 0.845(0.065) 0.781(0.062)
3 0.5 0.703(0.035) 0.511(0.115) 0.790(0.091) 0.758(0.088)
3.5 0.5 0.673(0.049) 0.527(0.121) 0.742(0.092) 0.793(0.059)
4 0.5 0.701(0.051) 0.521(0.115) 0.802(0.110) 0.718(0.068)
4.5 0.5 0.691(0.038) 0.520(0.145) 0.790(0.073) 0.785(0.060)
0.5 1 0.768(0.031) 0.541(0.041) 0.850(0.081) 0.779(0.109)
1 1 0.756(0.046) 0.524(0.074) 0.838(0.097) 0.841(0.019)
1.5 1 0.753(0.019) 0.545(0.092) 0.838(0.104) 0.826(0.021)
2 1 0.751(0.054) 0.488(0.094) 0.864(0.073) 0.828(0.043)
2.5 1 0.753(0.012) 0.585(0.102) 0.805(0.135) 0.827(0.040)
3 1 0.734(0.026) 0.569(0.116) 0.767(0.128) 0.783(0.106)
3.5 1 0.730(0.030) 0.573(0.108) 0.809(0.117) 0.784(0.103)
4 1 0.742(0.043) 0.567(0.101) 0.819(0.132) 0.775(0.117)
0.5 2 0.776(0.029) 0.547(0.087) 0.838(0.074) 0.836(0.047)
1 2 0.769(0.011) 0.584(0.141) 0.824(0.117) 0.818(0.044)
1.5 2 0.780(0.047) 0.572(0.119) 0.869(0.088) 0.814(0.071)
2 2 0.761(0.034) 0.603(0.090) 0.782(0.150) 0.826(0.038)
2.5 2 0.766(0.017) 0.572(0.081) 0.820(0.098) 0.790(0.076)
3 2 0.746(0.044) 0.586(0.114) 0.777(0.129) 0.779(0.124)
118
cross-validation folds. For example, by comparing the two DPFA models M+ and M−
with signal length = 0.5 (mins) and gap length = 0.5 (mins), this approach yields
the following five rhythm patterns as showing the most significant difference between
M+ and M−: $ff (which corresponds to the rhythm pattern [α3β2, α3β2], where α3β2
corresponds to a single window with activity level α3 and ECG type β2 as defined by
equation (5.5,5.6,5.7,5.8)), $ciic, $ici, $ffic, and $cii. Here for ease of presentation we
have switched to an alphabet consisting of single-letter symbols, the two alphabets
correspond to each other as follows
old alphabet α1β1 α2β1 α3β1 α1β2 α2β2 α3β2 α1β3 α2β3 α3β3
new alphabet a b c d e f g h i
and we use the $ symbol to denote the empty string. Please see Figure 5.28 for a
plot of the relative frequencies of all the states and the ten most significant rhythm
patterns with signal length = 0.5 (mins) and gap length = 0.5 (mins). Please also see
Table 5.23 for the five states with most difference between the relative frequencies in
DPFA M+ vs DPFA M− for various gap intervals and prediction intervals.
5.6.5 Discussion
This study in patients with AF showed that our novel DPFA algorithm can predict
the onset of AF with RVR associated with low levels of activity with AUC around
0.75 for intervals up to 4.5 minutes before the onset of the event. This is the first
study to evaluate the performance of prediction algorithms using the ECG along
with accelerometer data. Prediction of AF with rapid rates can result in personalized
treatment options for prevention and management of AF episodes that are likely to
be clinically significant. Our algorithm can help to distinguish between AF with
RVR episodes that occur unexpectedly at low levels of activity, thus more likely to
be clinically significant.
The machine learning techniques have shown impressive capability to analyze
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Table 5.23: Five states with most difference between the relative frequencies in DPFA







State1 State2 State3 State4 State5
0.5 0.5 $ff $ciic $ici $ffic $cii
1 0.5 $i $ciic $cii $icii $iffff
1.5 0.5 $iiiciici $iiiciii $ciic $icci $ciici
2 0.5 $ff $cii $ici $cifi $f
2.5 0.5 $ficific $ific $ificic $iiiciii $iffi
3 0.5 $fi $cii $ficific $ciic $icciic
3.5 0.5 $ficific $iccifici $iiiciicic $iccii $icific
4 0.5 $ff $cii $i $fi $icc
4.5 0.5 $cifici $icif $cific $cifi $fici
0.5 1 $iicciiiiciii $iicciiiic $iicciiiicii $iicciiiici $iicciiicii
1 1 $ificificifici $ificificific $iicifii $iicifiic $ciicicii
1.5 1 $ficifici $cific $ciici $cif $ficificificif
2 1 $ciic $cii $cific $ciii $iccii
2.5 1 $cific $ciii $icif $ciic $cicici
3 1 $ificiiic $ii $cificif $ficif $iccic
3.5 1 $i $ic $f $if $iiciici
4 1 $ificificifici $icci $iiccificii $iiccifii $ificificific
0.5 2 $ificificificifici $iiiiciiiicii $iiiiciiciicii $iiiiciiiiciii $ificific
1 2 $iiiiciicii $ificific $ifiic $ificificificif $ificificifici
1.5 2 $ificificifi $ificificificific $ii $ficifici $ificificificifici
2 2 $ici $icifi $icif $ffff $iccificifi
2.5 2 $iiccif $ificificific $iicc $iiccic $iiciiii
3 2 $iccii $fici $ficific $ficif $icif
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massive amounts of data and are an effective method for classification of arrhythmias
using ECG data. Despite being most commonly used in many areas, deep learning
algorithms have the drawback that their architecture represents a “Black Box” Topol
(2019). Their lack of transparency limits their clinical adoption, makes mechanistic
interpretation difficult and reduces their trustworthiness. Further, the disclosure of
meaningful details about medical treatment to patients requires the doctors to grasp
the fundamental inner workings of the devices they use to some degree Nagendran
et al. (2020). Explainability may also be required to justify the clinical validation
of machine learning algorithms in prospective studies and randomized clinical trials
Doshi-Velez and Kim (2017). Our DPFA model represents a novel and explainable
algorithm. This allows others to validate our algorithm in a diverse population of
patients and adopt it clinically if proven to be effective. Previous studies have used
the features extracted from the accelerometer data to give an overall impression of
patient activity over a period of time. However, these features can not fully capture
the variability in daily activity. It also misses the features within the activity signal
that can provide important physiological insights about the patient’s condition Yang
and Hsu (2010). Our approach shows that using the one-dimensional accelerometer
magnitude from the tri-axial raw accelerometer data can provide important infor-
mation that can augment the interpretation of the ECG and accelerometer signals
beyond the traditional features extracted from the signals.
Most methods for physiological data analysis depend heavily on pre-processing.
However, these methods tend to be less effective on noisy data, such as data collected
in real-time or in outpatient settings. Therefore, it is desirable to introduce new
methods that require minimal pre-processing to analyze such data, thus allowing
these insights to be applied to automated clinical decision making. In the previous
study, the DPFA method has showed to be particularly useful for the real-world noisy
data. Our algorithm does not rely on peak detection, requires minimal pre-processing
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and leads to good performance in the setting of noisy ECG signal. This provides a
significant advantage over existing algorithms when it is necessary to perform rapid
analysis in highly noisy environments. Thus DPFA algorithm can be useful for signals
captured by portable devices which are prone to noise.
Prediction can only be helpful if it results in specific action that can impact clinical
outcomes. In recent years, an increasing number of portable devices have been de-
veloped to monitor the physiological signals. Our algorithm provides a possibility for
real-time prediction of clinically meaningful arrhythmias using ECG signal together
with accelerometer signals with enough lag time for medical interventions.
This is the first algorithm that can identify features within the ECG that are capa-
ble of detecting and predicting periods of AF with RVR that are not associated with
high activity levels. This allows clinicians to distinguish between clinically significant
periods of AF and other periods. This has significant implications for the appropriate
treatment of patients with AF. Identifying physiologically significant episodes of AF
allows an opportunity to deliver just-in-time treatments that can be tailored for each
individual while avoiding the side effects related to daily medications.
5.6.6 Limitations
The first limitation of our study is the sample size. Our algorithm was validated
in a small subset of patients with AF. Although the number of patients included in
the study was small, there were numerous episodes available for training our algo-
rithm. The validity and generalizability of our algorithm needs to be tested in a wider
more diverse group of patients with AF. We sought to mediate the impact of patient
subtypes by leveraging a large number of episodes of AF in our patient population;
however, future work incorporating medication status, co-morbidities and other fac-
tors would allow for measuring algorithm performance within specific patient subsets
and ensure equal representation in the training dataset.
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The aim of our project was to predict AF with rapid ventricular rates and low
activity levels. Worsening AF symptom severity is associated with reduced daily
activity Semaan et al. (2020). The second limitation of the study is a lack of patient-
reported symptoms during periods of AF with RVR and low activity. Therefore, it
is difficult to ascertain symptom severity during these episodes. Future studies with
frequent momentary assessment of symptoms are needed to determine the relationship
between symptoms and AF with RVR episodes and low activity.
The third limitation is the interpretability of the activity threshold. In the study,
an arbitrary choice of 0.75 quantile MAD based on activity of the entire group is used
for classifying activity level. However, participants might have large differences in
activity level. To account for these differences, MAD threshold relative to individual
participants is also used for analysis. The average AUC for 0.5 minute-long prediction
intervals is 0.74±0.02, 1 minute-long is 0.75±0.01 and 2 minute-long is 0.78±0.01. The
2 minute-long prediction intervals showed most consistent results with AUC around
0.75 and smallest standard deviations. When tgap is less than 1.5 minutes, the AUC
ranges between 0.74 - 0.80. The AUC is above 0.69 for all prediction intervals. Figure
5.27 shows the prediction results based on activity events labeled based on participant
level MAD. We did not distinguish between different types of activity. It is possible
that certain forms of exercise (e.g., stationary cycling) may not be accounted for in the
present analysis. The MAD threshold used in the study is a relative MAD threshold
instead of an absolute MAD threshold. Studies have investigated different types of
activities with their MAD thresholds. However these studies Bakrania et al. (2016)
used accelerometer sensors attached to the hip or wrist regions while our sensors are
attached to the chest which make our MAD measurements incomparable with these
thresholds. There are several studies that investigate activity classification using chest
mounted tri-axial accelerometer devices Godfrey et al. (2011); Gjoreski et al. (2014);
Purwar et al. (2007); Gao et al. (2014) with signal processing and machine learning
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techniques, however they did not state thresholds of activities with MAD metric.
We tried to minimize this limitation by using both intra-individual and sample-level
activity distributions for the threshold. However, in the future if accelerometer data
can be collected with similar sensors and attached to wrists, the prediction results can
be better generalized. Both the accelerometer data and ECG data are collected as
continuous signals with timestamp when the device is attached to the participant, so
the non-wear time information is available and automatically removed, since our study
uses synchronized accelerometer and ECG signals. The non-wear time is unlikely to
affect our results on prediction of RVR with low activity level. But for future studies
it could be helpful to know the reason why the patient removed the device and if
it was a consequence of potential events. To this end, we plan to standardize and
automate the annotation process by intelligently mining the training data. We are
hopeful that such efforts will continue to improve of the performance of the algorithm
and further expand the scope of our approach.
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Figure 5.22: RVR with low activity prediction, AF Burden for all participant and
those included in the prediction of RVR with low activity.
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Figure 5.23: RVR with low activity prediction, prediction and gap intervals extrac-
tions.
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Figure 5.24: RVR with low activity prediction, classification of events using DPFA
model.
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Figure 5.25: RVR with low activity prediction, five-fold nested cross validation.
Figure 5.26: RVR with low activity prediction, AUC for RVR with low activity labeled
by group level MAD vs. Others with various prediction intervals.
AF duration of at least 30 seconds, trained with nested cross validation, activity
labeled by group level MAD.
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Figure 5.27: RVR with low activity prediction, AUC for RVR with low activity labeled
with participant level MAD vs. Others with various prediction intervals.
AF duration of at least 30 seconds, trained with nested cross validation, activity
labeled by participant level MAD.
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Figure 5.28: RVR with low activity, relative frequency of states for DPFA models.
Example, Signal Length = 0.5 (mins) , Gap Length= 0.5 (mins).
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CHAPTER VI
Summary, Implications and Conclusion
In this paper a novel DPFA based method is presented to classify and predict
cardiac arrhythmia events. The proposed method takes a probabilistic string ex-
tracted from physiological signals such as ECG in the training set as input, and via
frequency analysis, constructs the underlying state space and transition probabilities
of the DPFA model, directly from the input data. When applying the DPFA algo-
rithm to classification and prediction problems, the decisions are based on comparing
goodness-of-fit between the testing signal and various DPFA constructed from the
training signals.
A collection of datasets have been constructed for this study, including pub-
licly available benchmark datasets (DB1) for algorithm development and arrhythmia
events detection; a retrospective database collected with data at hospital bed-side
(DB2); prospective databases (DB4 and DB5) with signals collected from portable
devices and database with AFib patients with signals with portable devices (DB6).
Detection and prediction experiments have been conducted on various cardiac
arrhythmia types. The proposed algorithm has achieved an AUC of 0.95 in DB1 for
AFib detection; for AFib prediction the algorithm has achieved greater than 0.80 in
DB2 prediction with hospital bed-side data, AUC results are in the range of 0.79
to 0.87 for data collected from portable devices and 0.61 to 0.73 with data collected
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while in-vehicle. The proposed algorithm has achieved an AUC of 0.95 in DB1 for
SVT detection; for SVT prediction the algorithm has achieved greater than 0.75 in
DB2 prediction with hospital bed-side data, AUC results in the range of 0.78 to 0.92
for data collected from portable devices. Prediction experiment for SVT has not been
performed with in-vehicle data due to limited sample sizes. The proposed algorithm
has achieved an AUC of 0.97 in DB1 for VA detection; for VT prediction the algorithm
achieved around 0.75 in DB2 prediction with hospital bed-side data. VT prediction
experiment has not been performed with data collected from portable devices due to
limited sample sizes. The proposed algorithm has achieved an AUC around 0.71 to
0.74 for 2-minute-long signals for bradycardia prediction with hospital bed-side data.
Bradycardia prediction experiment has not been performed with data collected from
portable devices due to limited sample sizes. For prediction of RVR with low activity
events the model has achieved an overall AUC around 0.70 to 0.80 depending on the
lengths and gap sizes of the prediction intervals.
Comparing with other well-established methods, the proposed DPFA algorithm
has achieved equal or better classification results, even though in some cases the
advantage might not be statistically significant. In addition, the performance of the
proposed DPFA algorithm is almost identical with or without any pre-processing on
the data.
One of the limitations of our study is the sample size. Lack of events, especially in-
vehicle arrhythmia events, has hampered the performance of the algorithm. Secondly,
a lack of clinician reviewed annotations in databases has weaken the generalizability
of the algorithms. To overcome the annotation issue, carefully reviewed and con-
ducted automated annotation algorithms have been developed for various types of
AFib events. For data collected from the portable devices, FDA cleared Preventice’s
annotations have been used as labels. In the future study, a dataset with a larger
number of clinician annotated events will be helpful to further validate and compare
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the monitoring system with existing methods. Also, in this thesis the prediction re-
sults have been presented with events upto 5 minutes prior to the events, in future
studies a wider range of prediction intervals should be considered. The prediction of
RVR with low activity level experiment uses synchronized ECG with accelerometer
signals. In future studies, more types of physiological signals could be used since our
algorithm could be adapted for different types of signals.
To conclude, The work in the thesis could be deployed as a cardiac arrhythmia
monitoring and severe event prediction system which could alert patients and clini-
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